This document is a curriculum vitae for Dr. Michael S. Lauer that provides biographical information over 10 pages. It includes his education history, postdoctoral training, licensure and certifications, appointments, awards and honors, memberships, research interests, teaching experience, and publications. He is currently the Director of the Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute at the NIH in Bethesda, Maryland. The CV demonstrates an accomplished career in cardiology, epidemiology, and biomedical research leadership.
This document outlines guidelines from the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). It provides classifications for blood pressure levels, assessments of cardiovascular disease risk associated with blood pressure, and benefits of treating high blood pressure. The report recommends accurate office blood pressure measurements, ambulatory blood pressure monitoring, and self-monitoring of blood pressure. It also provides guidance on patient evaluation, laboratory tests, treatment options, and goals for controlling high blood pressure.
This curriculum vitae summarizes the professional experience and qualifications of Dr. John C. Ruckdeschel. He has over 40 years of experience in oncology, including serving as CEO of several major cancer centers. His educational background includes an MD from Albany Medical College and further training at NIH. He has held professorships at multiple universities and has received many honors for his contributions to oncology.
Rudra Trivedi has extensive research experience in exercise science and health psychology. He holds an MBA and MS in Exercise and Health Science. His research focused on chronic inflammation, alcohol consumption on college campuses, and physical activity levels in older adults. He has taught several exercise science labs and tutored student athletes. Currently he is a professional tutor at Ohio State University.
The document provides an overview of the National Library of Medicine Classification Scheme. It discusses that the scheme is used to organize library resources related to medicine and preclinical basic sciences. The document outlines the main components of the classification scheme, including the QS-QZ and W-WZ schedules that cover preclinical sciences and medicine/related subjects respectively. It also discusses how the classification system is structured, with topics grouped and enumerated, and explains how to read National Library of Medicine call numbers.
Christopher Willie is an experienced researcher with over 10 years conducting human physiology research. He has coordinated large, multi-group research expeditions to Nepal and has worked with elite athletes. Willie has a strong publication record, including over 40 peer-reviewed articles and a book chapter. He holds a PhD from UBC and has received several awards and scholarships for his research.
This document is a curriculum vitae for Venkat ramanarsaiah Bathem. It outlines his professional experience as a software engineer with over 4 years of experience working with the Informatica ETL tool on data warehousing projects. It also lists his educational background, including an MCA from NIT Raipur, technical skills including SQL, Java, C/C++, and certifications in software testing and Informatica. The CV describes 5 projects he has worked on for clients in banking, financial services and healthcare.
Jerry Vigil CV - Software Engineer - San Francisco, CA, USAMktNeutral
Jerry Vigil has over 10 years of experience in front-end software engineering, quality assurance, test automation, and database development. He is looking to apply his full-stack skills to create effective and reliable software solutions at an innovative company.
This document outlines guidelines from the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). It provides classifications for blood pressure levels, assessments of cardiovascular disease risk associated with blood pressure, and benefits of treating high blood pressure. The report recommends accurate office blood pressure measurements, ambulatory blood pressure monitoring, and self-monitoring of blood pressure. It also provides guidance on patient evaluation, laboratory tests, treatment options, and goals for controlling high blood pressure.
This curriculum vitae summarizes the professional experience and qualifications of Dr. John C. Ruckdeschel. He has over 40 years of experience in oncology, including serving as CEO of several major cancer centers. His educational background includes an MD from Albany Medical College and further training at NIH. He has held professorships at multiple universities and has received many honors for his contributions to oncology.
Rudra Trivedi has extensive research experience in exercise science and health psychology. He holds an MBA and MS in Exercise and Health Science. His research focused on chronic inflammation, alcohol consumption on college campuses, and physical activity levels in older adults. He has taught several exercise science labs and tutored student athletes. Currently he is a professional tutor at Ohio State University.
The document provides an overview of the National Library of Medicine Classification Scheme. It discusses that the scheme is used to organize library resources related to medicine and preclinical basic sciences. The document outlines the main components of the classification scheme, including the QS-QZ and W-WZ schedules that cover preclinical sciences and medicine/related subjects respectively. It also discusses how the classification system is structured, with topics grouped and enumerated, and explains how to read National Library of Medicine call numbers.
Christopher Willie is an experienced researcher with over 10 years conducting human physiology research. He has coordinated large, multi-group research expeditions to Nepal and has worked with elite athletes. Willie has a strong publication record, including over 40 peer-reviewed articles and a book chapter. He holds a PhD from UBC and has received several awards and scholarships for his research.
This document is a curriculum vitae for Venkat ramanarsaiah Bathem. It outlines his professional experience as a software engineer with over 4 years of experience working with the Informatica ETL tool on data warehousing projects. It also lists his educational background, including an MCA from NIT Raipur, technical skills including SQL, Java, C/C++, and certifications in software testing and Informatica. The CV describes 5 projects he has worked on for clients in banking, financial services and healthcare.
Jerry Vigil CV - Software Engineer - San Francisco, CA, USAMktNeutral
Jerry Vigil has over 10 years of experience in front-end software engineering, quality assurance, test automation, and database development. He is looking to apply his full-stack skills to create effective and reliable software solutions at an innovative company.
The document contains personal and professional information about Oscar Alirío Reyes Castro. It includes his address, marital status, date of birth, contact information, as well as work experience, education history, skills and qualifications. He has over 20 years of experience in project management, business management and leadership roles. He also holds a Master's degree in Management and several professional certificates in areas like data science, project management, and mobile application development.
- The document is a curriculum vitae that outlines Yury Velikanov's professional experience and qualifications.
- It details over 16 years of experience as an Oracle DBA consultant with extensive experience implementing, maintaining, and tuning Oracle database and applications systems.
- Yury has held roles such as Oracle Apps DBA Team Technical Lead, Senior Oracle DBA consultant, and Technical Architect on various projects for companies including Pythian, Macquarie Bank, and Telenor.
Michael Ragge is seeking a senior-level position in the London area requiring work visa sponsorship. He has over 27 years of experience in business, analytics, and IT. He provides concise summaries of relevant technical skills and experience in roles such as solutions architect, project manager, and consultant for various companies and as an independent consultant.
This curriculum vitae summarizes Ines Mergel's educational and professional background. She is currently an Assistant Professor at Syracuse University, with affiliations in Public Administration and Information Studies. Her education includes a Dr. oec. from University of St. Gallen and an MBA from University of Kassel. Her research focuses on social media adoption in government and network analysis. She has published numerous journal articles, book chapters, and two authored books on these topics.
This curriculum vitae summarizes the professional experience and qualifications of Mala R. Chinoy. She has over 20 years of experience as a pulmonary developmental biologist and has held various academic positions, including as a Professor of Pediatrics and Professor of Pediatric Surgery and Biochemistry. Currently, she works as an independent consultant in the private sector and also served as the Federal Project Business Manager for Pennsylvania's Workforce Data Quality Initiative from 2012 to 2015. She has an extensive record of research, publishing over 57 research articles and authoring several book chapters.
Heidi Kraay is a playwright, writer, and theater maker based in Boise, Idaho. She holds an MFA from California Institute of Integral Studies and a BA from Boise State University. Kraay has written and produced numerous plays, and has taught playwriting, acting, and theater workshops across Idaho. She is also published in various literary journals for her poetry, fiction, and creative nonfiction. Kraay's extensive resume shows her expertise and experience in writing, directing, acting, and technical theater work.
Stephen G. Barr is an entrepreneur, startup adviser, investor, author, and publisher. He has over 35 years of experience in various fields including real estate, banking, winemaking, publishing, and technology startups. He currently advises and invests in startups, serves on advisory boards, publishes digital content, and works as a subject matter expert providing strategic advice. He has received several honors and awards for his work and has a wide range of professional and personal interests.
Joseph Bejjani has over 30 years of experience in information systems and management. He has led global IT organizations of up to 400 employees supporting large multinational companies. Most recently, he has served as the Chief Information Officer for Zodiac Pool Solutions, where he developed their strategic IT plan and consolidated systems from acquisitions. Prior to that, he held CIO roles at Zodiac Marine & Pool and several divisions of Roche, where he established IT organizations and implemented major systems.
This document provides a summary of Sorin A. Matei's academic background and achievements. It includes his academic appointments as a professor at Purdue University, awards and honors received, memberships, grants received, and publications. Some key details include that he is currently a professor at Purdue University, has received over $1 million in external research funding, has published several books and over 15 peer-reviewed journal articles, and has received many honors and awards for his research including a Fulbright Specialist grant.
Abdullah Aziz is a full stack MEAN developer and iOS developer with experience in programming, problem solving, and IoT. He has worked as a software engineer developing video calling applications using WebRTC and XMPP protocols. He has also worked as a head teacher assistant teaching programming fundamentals and as an Asp.Net developer developing a platform for freelance writers. Currently, he works as an associate software engineer implementing a streaming server in Node.js. He holds a BSCS from Punjab University College of Information Technology and has taken online courses in full stack development, iOS development, big data, and IoT.
Dan J. Wang is a PhD candidate in sociology at Stanford University expected to graduate in 2013. His dissertation focuses on skilled return migration and global knowledge flows. He has a BA from Columbia University and MA from Stanford. His research interests include organizational theory, economic sociology, social networks, and globalization. He has published papers in top journals and has received honors including the Kauffman dissertation fellowship.
This document provides a curriculum vitae for Ibrahim Abdel-Karim Ahmed Abdel-Rahman that includes his personal details, education history, professional experience, publications, courses taught, and workshops/seminars attended. It outlines his background as a lecturer in chemistry with a B.Sc. from the University of Jordan and M.Sc. from Kuwait University who currently teaches at the University of Sharjah in the United Arab Emirates.
This document is a resume for Laura Boley that summarizes her education and work experience. She received a Bachelor of Science degree in Applied Science with a major in Fashion Merchandising from Youngstown State University. Her current role is District Sales Manager at ADP in Pittsburgh, where she has exceeded sales quotas and been promoted. Prior roles include Manager/Visual Product Manager at Eddie Bauer, Store Manager at Cache, and Assistant Store Manager at Aeropostale.
Robin Roderick is an electrical engineer and LEED AP seeking a position as an electrical engineer or project manager. He has over 40 years of experience in electrical design, startup, testing and commissioning of various public works, commercial, educational, and other facilities. His project experience includes electrical design work for water treatment plants, airports, data centers, schools, banks, and other facility types.
James H. Robinson has over a decade of experience in business intelligence and database development. He has worked as a consultant and in various full-time roles implementing BI systems using tools like SQL Server, Power BI, and Tableau. Robinson is a certified scrum master with experience writing requirements, managing projects, and developing ETL processes.
Fahim Jamal has over 16 years of experience as a Team Lead Support Engineer for AT&T providing technical support for internal employees and business customers. He has expertise in networking, including configuring Wide Area Networks, Local Area Networks, firewalls, servers, routers, and switches. Fahim holds a Bachelor's degree in Electrical Engineering from San Francisco State University and professional certifications including CCNA and CCNP.
This curriculum vitae outlines the education and career of Dr. Jeffrey C. Fink. It details his education, including degrees from Clark University and Case Western Reserve University School of Medicine. It provides a comprehensive history of his academic appointments and certifications, clinical and research activities, teaching experience, grant support, and publications. Dr. Fink currently serves as Professor of Medicine and Epidemiology and Chief of General Internal Medicine at the University of Maryland School of Medicine.
This curriculum vitae outlines the education and career of Dr. Sarah A. Chambers. She received her B.A. from Harvard University and her M.D. from Columbia University. She completed her pediatric training and fellowships at Children's Hospital of New York. Dr. Chambers is currently an Assistant Professor at Albert Einstein College of Medicine, the Director of the Fetal Heart Program at Children's Hospital at Montefiore, and an attending physician at multiple hospitals in the Bronx, NY area. She has authored several publications and book chapters, and actively participates in teaching, research, and quality improvement initiatives related to pediatric cardiology and fetal echocardiography.
This document provides a curriculum vitae for Dr. David A. Dowe, including his education, postgraduate training, faculty appointments, hospital appointments, publications, awards, and teaching experience. It details that he received his medical degree and completed his residency at SUNY Health Center, has been a practicing radiologist for over 25 years, and is currently the medical director of the coronary CTA program at Atlantic Medical Imaging in New Jersey where he has given over 150 national and international lectures on coronary CTA.
This curriculum vitae summarizes the professional experience and qualifications of Dr. Joseph S. Weiner. It details his education, including degrees in chemistry, physiology, and medicine. It provides a comprehensive overview of his clinical training and positions in psychiatry and consultation-liaison psychiatry. It also lists his academic appointments, areas of clinical expertise, administrative roles, and awards and honors received over his career in psychiatry and physician communication training.
This document outlines the career history and qualifications of Dr. Jennifer Newman Keagle, a plastic surgeon specializing in craniofacial surgery. It lists her education, including medical school and residencies, employment history at hospitals and universities, board certifications, research experience, publications, presentations, courses taken, and professional memberships. She currently practices privately and at hospitals in Los Angeles, California.
Steven B. Hammer has extensive experience in education and research. He holds a Ph.D. in Biomedical Sciences from Kent State University and has worked at Indian River State College since 2010, where he currently serves as Department Chair. His research has focused on the interactions between exercise, aging, ethanol, and the circadian timing system. He has published several papers and textbooks on these topics and presented his research at numerous conferences.
The document contains personal and professional information about Oscar Alirío Reyes Castro. It includes his address, marital status, date of birth, contact information, as well as work experience, education history, skills and qualifications. He has over 20 years of experience in project management, business management and leadership roles. He also holds a Master's degree in Management and several professional certificates in areas like data science, project management, and mobile application development.
- The document is a curriculum vitae that outlines Yury Velikanov's professional experience and qualifications.
- It details over 16 years of experience as an Oracle DBA consultant with extensive experience implementing, maintaining, and tuning Oracle database and applications systems.
- Yury has held roles such as Oracle Apps DBA Team Technical Lead, Senior Oracle DBA consultant, and Technical Architect on various projects for companies including Pythian, Macquarie Bank, and Telenor.
Michael Ragge is seeking a senior-level position in the London area requiring work visa sponsorship. He has over 27 years of experience in business, analytics, and IT. He provides concise summaries of relevant technical skills and experience in roles such as solutions architect, project manager, and consultant for various companies and as an independent consultant.
This curriculum vitae summarizes Ines Mergel's educational and professional background. She is currently an Assistant Professor at Syracuse University, with affiliations in Public Administration and Information Studies. Her education includes a Dr. oec. from University of St. Gallen and an MBA from University of Kassel. Her research focuses on social media adoption in government and network analysis. She has published numerous journal articles, book chapters, and two authored books on these topics.
This curriculum vitae summarizes the professional experience and qualifications of Mala R. Chinoy. She has over 20 years of experience as a pulmonary developmental biologist and has held various academic positions, including as a Professor of Pediatrics and Professor of Pediatric Surgery and Biochemistry. Currently, she works as an independent consultant in the private sector and also served as the Federal Project Business Manager for Pennsylvania's Workforce Data Quality Initiative from 2012 to 2015. She has an extensive record of research, publishing over 57 research articles and authoring several book chapters.
Heidi Kraay is a playwright, writer, and theater maker based in Boise, Idaho. She holds an MFA from California Institute of Integral Studies and a BA from Boise State University. Kraay has written and produced numerous plays, and has taught playwriting, acting, and theater workshops across Idaho. She is also published in various literary journals for her poetry, fiction, and creative nonfiction. Kraay's extensive resume shows her expertise and experience in writing, directing, acting, and technical theater work.
Stephen G. Barr is an entrepreneur, startup adviser, investor, author, and publisher. He has over 35 years of experience in various fields including real estate, banking, winemaking, publishing, and technology startups. He currently advises and invests in startups, serves on advisory boards, publishes digital content, and works as a subject matter expert providing strategic advice. He has received several honors and awards for his work and has a wide range of professional and personal interests.
Joseph Bejjani has over 30 years of experience in information systems and management. He has led global IT organizations of up to 400 employees supporting large multinational companies. Most recently, he has served as the Chief Information Officer for Zodiac Pool Solutions, where he developed their strategic IT plan and consolidated systems from acquisitions. Prior to that, he held CIO roles at Zodiac Marine & Pool and several divisions of Roche, where he established IT organizations and implemented major systems.
This document provides a summary of Sorin A. Matei's academic background and achievements. It includes his academic appointments as a professor at Purdue University, awards and honors received, memberships, grants received, and publications. Some key details include that he is currently a professor at Purdue University, has received over $1 million in external research funding, has published several books and over 15 peer-reviewed journal articles, and has received many honors and awards for his research including a Fulbright Specialist grant.
Abdullah Aziz is a full stack MEAN developer and iOS developer with experience in programming, problem solving, and IoT. He has worked as a software engineer developing video calling applications using WebRTC and XMPP protocols. He has also worked as a head teacher assistant teaching programming fundamentals and as an Asp.Net developer developing a platform for freelance writers. Currently, he works as an associate software engineer implementing a streaming server in Node.js. He holds a BSCS from Punjab University College of Information Technology and has taken online courses in full stack development, iOS development, big data, and IoT.
Dan J. Wang is a PhD candidate in sociology at Stanford University expected to graduate in 2013. His dissertation focuses on skilled return migration and global knowledge flows. He has a BA from Columbia University and MA from Stanford. His research interests include organizational theory, economic sociology, social networks, and globalization. He has published papers in top journals and has received honors including the Kauffman dissertation fellowship.
This document provides a curriculum vitae for Ibrahim Abdel-Karim Ahmed Abdel-Rahman that includes his personal details, education history, professional experience, publications, courses taught, and workshops/seminars attended. It outlines his background as a lecturer in chemistry with a B.Sc. from the University of Jordan and M.Sc. from Kuwait University who currently teaches at the University of Sharjah in the United Arab Emirates.
This document is a resume for Laura Boley that summarizes her education and work experience. She received a Bachelor of Science degree in Applied Science with a major in Fashion Merchandising from Youngstown State University. Her current role is District Sales Manager at ADP in Pittsburgh, where she has exceeded sales quotas and been promoted. Prior roles include Manager/Visual Product Manager at Eddie Bauer, Store Manager at Cache, and Assistant Store Manager at Aeropostale.
Robin Roderick is an electrical engineer and LEED AP seeking a position as an electrical engineer or project manager. He has over 40 years of experience in electrical design, startup, testing and commissioning of various public works, commercial, educational, and other facilities. His project experience includes electrical design work for water treatment plants, airports, data centers, schools, banks, and other facility types.
James H. Robinson has over a decade of experience in business intelligence and database development. He has worked as a consultant and in various full-time roles implementing BI systems using tools like SQL Server, Power BI, and Tableau. Robinson is a certified scrum master with experience writing requirements, managing projects, and developing ETL processes.
Fahim Jamal has over 16 years of experience as a Team Lead Support Engineer for AT&T providing technical support for internal employees and business customers. He has expertise in networking, including configuring Wide Area Networks, Local Area Networks, firewalls, servers, routers, and switches. Fahim holds a Bachelor's degree in Electrical Engineering from San Francisco State University and professional certifications including CCNA and CCNP.
This curriculum vitae outlines the education and career of Dr. Jeffrey C. Fink. It details his education, including degrees from Clark University and Case Western Reserve University School of Medicine. It provides a comprehensive history of his academic appointments and certifications, clinical and research activities, teaching experience, grant support, and publications. Dr. Fink currently serves as Professor of Medicine and Epidemiology and Chief of General Internal Medicine at the University of Maryland School of Medicine.
This curriculum vitae outlines the education and career of Dr. Sarah A. Chambers. She received her B.A. from Harvard University and her M.D. from Columbia University. She completed her pediatric training and fellowships at Children's Hospital of New York. Dr. Chambers is currently an Assistant Professor at Albert Einstein College of Medicine, the Director of the Fetal Heart Program at Children's Hospital at Montefiore, and an attending physician at multiple hospitals in the Bronx, NY area. She has authored several publications and book chapters, and actively participates in teaching, research, and quality improvement initiatives related to pediatric cardiology and fetal echocardiography.
This document provides a curriculum vitae for Dr. David A. Dowe, including his education, postgraduate training, faculty appointments, hospital appointments, publications, awards, and teaching experience. It details that he received his medical degree and completed his residency at SUNY Health Center, has been a practicing radiologist for over 25 years, and is currently the medical director of the coronary CTA program at Atlantic Medical Imaging in New Jersey where he has given over 150 national and international lectures on coronary CTA.
This curriculum vitae summarizes the professional experience and qualifications of Dr. Joseph S. Weiner. It details his education, including degrees in chemistry, physiology, and medicine. It provides a comprehensive overview of his clinical training and positions in psychiatry and consultation-liaison psychiatry. It also lists his academic appointments, areas of clinical expertise, administrative roles, and awards and honors received over his career in psychiatry and physician communication training.
This document outlines the career history and qualifications of Dr. Jennifer Newman Keagle, a plastic surgeon specializing in craniofacial surgery. It lists her education, including medical school and residencies, employment history at hospitals and universities, board certifications, research experience, publications, presentations, courses taken, and professional memberships. She currently practices privately and at hospitals in Los Angeles, California.
Steven B. Hammer has extensive experience in education and research. He holds a Ph.D. in Biomedical Sciences from Kent State University and has worked at Indian River State College since 2010, where he currently serves as Department Chair. His research has focused on the interactions between exercise, aging, ethanol, and the circadian timing system. He has published several papers and textbooks on these topics and presented his research at numerous conferences.
This curriculum vitae outlines the career and qualifications of Joseph P. Hanna M.D. It summarizes his positions, including Associate Professor at Case Western Reserve University Department of Neurology since 2007. It also lists his employment history as Executive Director of MetroHealth Medical Center's Specialty Care Patient Care Unit from 2009 to 2015, and Interim and Designated Chair of Case Western Reserve University, MetroHealth System Department of Neurology since 1997. Finally, it provides an overview of his education, certifications, licensures, professional affiliations and committees.
This curriculum vitae summarizes the educational and professional background of Dr. Ishwarlal Jialal. He received his medical degrees from the University of Natal Medical School in South Africa and completed fellowships in the US. He has held faculty appointments at several universities and currently serves as a professor of pathology and internal medicine at UC Davis. His clinical expertise is in endocrinology, diabetes, and metabolism.
This document provides biographical and professional information about Dr. James Joseph Burns. It details his education, including obtaining a BS from the United States Naval Academy, an MD from Pennsylvania State University, and an MPH from University of Massachusetts. It outlines his medical training and licenses. It also lists his extensive academic appointments and awards over his career in adolescent medicine, pediatrics, and public health.
Dr. John Catanzaro is a naturopathic physician specializing in integrative oncology and personalized medicine. He received his ND from Bastyr University and has additional certifications in genetics and theology. He has owned several wellness clinics and founded non-profits focused on cancer research. Currently, he works as a physician consultant providing functional genetics testing and counseling.
This document is a curriculum vitae for Dr. John J. Iacuone, a pediatric hematologist-oncologist. It details his education, including receiving an M.D. from Indiana University School of Medicine in 1973 and an M.B.A. from Texas Tech University in 2007. It lists his medical licenses, certifications, academic and hospital appointments, lectures, honors, professional affiliations, administrative roles including serving as President and Chief Clinical Officer of multiple companies, and publications. The CV provides a comprehensive overview of Dr. Iacuone's qualifications and experience in pediatric oncology and healthcare administration.
Northwestern University Feinberg School of Medicine, Department of
Anesthesiology, 1984–1988
Northwestern University Feinberg School of Medicine, Department of
Anesthesiology, 1988–1995
Northwestern University Feinberg School of Medicine, Department of
Anesthesiology, 1995–2003
Associate:
Northwestern University Feinberg School of Medicine, Department of
Anesthesiology, 2003–2009
Professor:
Northwestern University Feinberg School of Medicine, Department of
Anesthesiology, 2009–present
Lectures:
Northwestern University Feinberg School of Medicine, Department of
Anesthesiology, 1984–present:
This document provides biographical information about John Barnard, including his education, professional experience, awards, grants, and publications. It lists that he received a Ph.D. from the University of Chicago and B.S. from Cornell University. His professional experience includes positions at Harvard University, deCODE Genetics, and the Cleveland Clinic Foundation, where he currently works. He has received awards from the University of Chicago and Harvard University. Grants listed include roles as Principal Investigator, Co-Investigator, and Core Director on projects related to genetics, cardiovascular disease, and neuroscience. The document concludes with a list of refereed publications where Barnard is the lead or senior author.
This curriculum vitae summarizes the career and qualifications of Dr. David S. Baskin. It details his education, including degrees from Swarthmore College and Mt. Sinai School of Medicine. It outlines his medical training and licensure, as well as his extensive faculty positions at institutions including Baylor College of Medicine, University of Houston, and Weill Cornell Medical College. The CV also lists numerous honors, awards, visiting professorships, committee memberships, and roles in medical societies that demonstrate his expertise and leadership in neurosurgery over several decades.
This curriculum vitae summarizes the career and qualifications of Anthony J. Cusano, M.D. It outlines his education, including a B.A. from Cornell University in 1977 and an M.D. from the University of Vermont College of Medicine in 1981. It then details his medical residencies and fellowships from 1981-1988 and his appointments as an attending physician from 1988 to the present at various hospitals, specializing in nephrology, internal medicine, and emergency medicine. It also lists his board certifications, professional honors, teaching experience, research presentations, professional experience, service, and publications.
This document provides biographical and professional information about Dr. Michael Slater, an emergency physician. It includes his education, certifications, employment history, faculty appointments, academic experience, scholarly activities, hospital affiliations, committee service, and personal information. Dr. Slater received his medical degrees from Harvard Medical School and The Medical College of Pennsylvania. He is board certified in emergency medicine and licensed to practice in Illinois. He currently works as the Quality Improvement Director at Mt. Sinai Hospital in Chicago.
This document is the curriculum vitae of Dr. Michael S. Cardwell, revised on March 1, 2016. It summarizes his educational and professional background over several decades, including positions held, publications, certifications, and hospital affiliations. Dr. Cardwell is currently a Maternal Fetal Medicine Specialist at Summa Maternal Fetal Medicine in Akron, Ohio. He has over 30 years of experience in maternal-fetal medicine, obstetrics and gynecology, and has held numerous teaching and administrative roles.
Abraham Perl is a medical student at Tel Aviv University expected to graduate in 2018 with a Doctor of Medicine degree. He earned a Bachelor's and Master's degree in Philosophy from Queens College, City University of New York in 2015 with honors and a 3.84 GPA. His experience includes tutoring, research, and volunteering in medical settings. He has published two papers and presented at a conference on ethics. His areas of interest include bioethics, philosophy of religion, and translational medicine.
My board certifications are in Neurology, Biochemical Genetics, and Molecular Genetics. After selling my molecular and biochemical diagnostics company in 2015, I have been focused on peer reviewed publications and advancing the field of Precision Medicine.
The document is a curriculum vitae for Dr. Sachin Jogal, an Assistant Professor of Pediatrics specializing in hematology, oncology, and bone marrow transplant. It details his education, including undergraduate and medical degrees, as well as his postgraduate training and fellowships. It also lists his faculty appointments, awards, publications, presentations, committee involvement, and community service activities.
1. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 1
Michael S. Lauer, MD, FACC, FAHA
CURRICULUM VITAE
NAME: Michael Solon Lauer, MD, FACC, FAHA
ADDRESS: Home: 12101 Ravenwood Court
Silver Spring, MD 20902
Business: 6701 Rockledge Drive, Room 8128
Bethesda, MD 20892
Phone: 301 435 0422 (business)
Email: lauermichael@yahoo.com (personal)
lauerm@nhlbi.nih.gov (business)
PLACE OF BIRTH: Wynnewood, Pennsylvania (July 11, 1961)
FAMILY: Married (1989) to Dr. Robin Avery
Nathan Max (born November 7, 1991)
Daniel Akiva (born May 31, 1994)
EDUCATION:
1983 BS Rensselaer Polytechnic Institute (summa cum laude), Troy,
New York
1985 MD Albany Medical College (magna cum laude), Albany, New York
1989-1990 Program in Clinical Effectiveness, Harvard School of Public
Health, Boston, MA
2004 Josiah Macy Scholar in Physician Education, Program for
Physician Educators, Harvard Medical School and Harvard
Graduate School of Education, Boston and Cambridge, MA
2010 NIH Senior Leadership Program (University of Maryland)
POSTDOCTORAL TRAINING:
1985-1986 Intern in Medicine, Massachusetts General Hospital and Harvard
Medical School, Boston
1986-1988 Resident in Medicine, Massachusetts General Hospital and
Harvard Medical School, Boston
1988-1991 Clinical Fellow in Medicine (Cardiology), Harvard Medical
2. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 2
School and Beth Israel Hospital, Boston
1990-1991 Research Fellow, Framingham Heart Study and Boston University
Medical School, Framingham, MA
LICENSURE AND CERTIFICATION:
1987 Massachusetts License Registration
1988 Specialty Certification (ABIM) in Internal Medicine
1991 Subspecialty Certification (ABIM) in Cardiovascular Disease
1993 Ohio License Registration
2001 Subspecialty Recertification (ABIM) in Cardiovascular Disease
2011 Subspecialty Recertification (ABIM) in Cardiovascular Disease
(top decile on April 11, 2011, secure examination)
HOSPITAL, INSTITUTIONAL, AND EXECUTIVE LEADERSHIP APPOINTMENTS:
1991-1993 Physician, Lahey Clinic Medical Center and Harvard Medical
School, Burlington, MA
1993-2007 Staff, Cleveland Clinic Foundation, Cleveland, Ohio
1997-2004 Co-director, Coronary Intensive Care Unit, Cleveland Clinic
Foundation, Cleveland, Ohio
1997-2007 Vice Chair, Cleveland Clinic Foundation Institutional Review
Board
1999-2007 Director, Exercise Laboratory, Cleveland Clinic Foundation,
Cleveland, Ohio
2007-2009 Director, Division of Prevention and Population Science (DPPS),
National Heart, Lung, and Blood Institute (NHLBI/NIH),
Bethesda, Maryland
Oversight of 50 FTEs, research portfolio of ~$300 million
3. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 3
2009- Director, Division of Cardiovascular Sciences (DCVS),
National Heart, Lung, and Blood Institute (NHLBI/NIH),
Bethesda, Maryland
Oversight of 123 FTEs, research portfolio of ~$1.5 billion
AWARDS AND HONORS:
1979 Salutatorian, Shenendehowa Central School, Clifton Park, NY
1982 Dean's Outstanding Research Award, Albany Medical College
Daggett Prize in Anatomy, Albany Medical College
1982 Knudson Prize in Biochemistry, Albany Medical College
Townsend Prize in Physiology, Albany Medical College
1983 Glen H. Leak Memorial Fellowship, American Cancer Society
Research Award, Association of Medical Schools of NY
Elected Sigma Xi
Alpha Omega Alpha
BS, summa cum laude, Rensselaer Polytechnic Institute
1984 Henry Schaeffer Prize in Pathology, Albany Medical College
1985 MD magna cum laude, Albany Medical College
1989 Kellogg Foundation Fellowship for study at the Harvard
School of Public Health
1993 Elected Fellow, American College of Cardiology
1996 Merck American College of Cardiology/European Society of
Cardiology International Exchange Fellowship
Distinguished Teacher Award, Cleveland Clinic Foundation
1997 Named First Vice Chair – CCF Institutional Review Board
2000 Paper of Dr. Christopher Cole, a fellow under my direct
supervision, selected as Finalist in the American College of
Cardiology Young Investigator Award Competition; paper
received honorable mention
2000 Named as Contributing Editor, JAMA (ongoing)
2000-2001 Awarded two-year Established Investigator Grant, American Heart
4. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 4
Association (0040244N), $140,000 over two years.
2001 Named Vice-Chair of the Exercise, Cardiac Rehabilitation, and
Prevention Committee of the Council of Clinical Cardiology,
American Heart Association.
2001-2004 NIH R01 HL-66004 grant on Heart Rate Recovery and Mortality
for $660,000.
2003 Named Chairman of the Exercise, Cardiac Rehabilitation, and
Prevention Committee of the Council of Clinical Cardiology,
American Heart Association.
2003 Invited Guest Lecturer, 50th
Annual Meeting of the Israel Heart
Society, Tel Aviv, Israel.
2004 Michael Pollock State-of-the-Art Lecturer, American Heart
Association.
2004-2007 NIH R01 HL072771-01Al grant on Logical Analysis Data for
$1,032,000.
2004 Paper of Hitinder S. Gurm MD – Honorable Mention – William E.
Lower Award. Clinical First Prize under my direct supervision.
2005 Paper of Rohit Bhatheja, MD – Honorary Award Winner (Echo-
nuclear paper) – William E. Lower Award under my direct
supervision.
2005 Elected member of American Society for Clinical Investigation
Award (ASCI)
2005 Reappointment as Professor of Medicine in the Cleveland Clinic
Lerner College of Medicine of Case Western Reserve University
for academic year.
2005 The Marie and Sam Miller Professional Excellence Award,
Scientific Achievement Award in Clinical Research
2005 Appointed Professor of Epidemiology and Biostatistics, Case
Western Reserve University School of Medicine
2006 Center for Clinical Investigation, Office of Faculty Affairs,
Secondary Appointment, Case Western Reserve University School
of Medicine
5. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 5
2006 Candidate for Cardiovascular Medicine Chair, Cleveland Clinic
2006 Visiting Professorships, University of Alberta and Indiana
University
2006 Torgny Sjoenstrand Honorary Lecture in Clinical Physiology
Annual Meeting of the Swedish Society of Medicine
2006 Scholarship in Teaching Award, Case Western Reserve University
School of Medicine (for Clinical Research Skills Block)
2007 Fellow (Dr. Esther Kim) wins first place, Young Investigator
Award for Clinical Research
American College of Cardiology, March, 2007
2008 Ancel Keys Lecture, American Heart Association
2009 National Institutes of Health Awards of Merit (2) for work on
NHLBI Short Detail Program
NHLBI Critical Reading Website (Today’s News blog)
2010 National Institutes of Health Award of Merit for work on
NHLBI Grand Opportunities Exome Sequencing Project
National Institutes of Health Director’s Awards for work on:
Office of the Director Team on Comparative Effectiveness
Research Through ARRA and Beyond
National Institutes of Health Equal Employment Opportunity
(EEO) 2010 Award of the Year: “For building a diverse
professional staff and promoting the Spirit of Fairness, Equality,
and Inclusion”
2012
NHBLI Merit Award “For Activities in Comparative Effectiveness
Research”
Arthur S. Flemming Award for exceptional service in Federal
Government “For [playing] a key role in setting the national
cardiovascular research agenda and [being] example in
empowering his staff through creation of an active learning
environment.”
6. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 6
2013
NIH Director’s Group Award: “NINDS Stroke Research Priorities
Planning Team, for extraordinary leadership, perseverance, and creativity
in coordinating and implementing the NINDS Stroke Research Priorities
planning effort.”
NIH Director’s Group Award: “The Health Care Systems Research
Collaboratory, for planning, developing innovative solicitations, review
and launch of the Health Care Systems (HCS) Research Collaboratory.”
NHLBI Director’s Individual Award: “In recognition of the extraordinary
work to promote individual and collective learning at the NHLBI.”
2014
NHLBI Director’s Group Award: “InCites Working Group – for the
dedication and collaboration exhibited by the trans-NHLBI InCites
Working Group in building a model learning environment for portfolio
analysis at the Institute.”
MEMBERSHIPS, OFFICES AND COMMITTEE ASSIGNMENTS (selected examples):
1989- American College of Physicians
1999-2007 American Medical Association
1993-1997 Cleveland Clinic Committee on Medical Records and Statistics
1994-2007 Cleveland Clinic Institutional Review Board
1995-2000 Cleveland Clinic Electronic Medical Records Committee
1997-2007 Vice-Chairman, Cleveland Clinic Institutional Review Board
2000-2007 Contributing Editor, JAMA
1998-2002 American College of Cardiology, Coding and Nomenclature
Committee
2003-2007 Professor of Medicine CCLCM of CWRU
2003-2005 Admissions Committee of the Cleveland Clinic Lerner College of
Medicine of Case Western Reserve University
7. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 7
2004-2007 “MAC” Multidisciplinary Advisory Committee – Director,
Richard A. Rudick, M.D. – Cleveland Clinic Foundation, K12
Program of the National Institutes of Health
2004-2007 Cleveland Clinic Lerner College of Medicine Research Curriculum
Committee
2005-2007 Cleveland Clinic Lerner College of Medicine Physicians Advisors
Committee
2005-2007 Program Oversight Committee for the MD/MS Biomedical
Investigation Program at CWRU
2005-2007 Annual Scientific Sessions Program Committee of the American
College of Cardiology
2005-2007 Lower & Peskind Awards Committee
2005-2007 Selected ad hoc member of NIH Study Section on Human
Services Research
2005-2007 ACCF/AHA Writing Committee to Update the 2000 Clinical
Expert Consensus Document on EBCT for the Diagnosis and
Prognosis of Coronary Artery Disease
2005- American Association for the Advancement of Science (AAAS)
2005-2007 Professor, Department of Epidemiology and Biostatistics, Case
Western Reserve University School of Medicine
2006 NIH Study Section Member, (ZHL1 CSR-H (M1). Bethesda MD
2006 Acute Cardiac Care Abstract Grader for Prague, Czech Republic
2006 ACCF/AHA Writing Committee to Develop a Clinical Expert
Consensus Document on Coronary Artery Calcium Scoring by
Computed Tomography in Global Cardiovascular Risk Assessment
and in Evaluation of Patients with Chest Pain
2006-2007 Research Education Committee, CCLCM of CWRU
2006-2007 PhD Molecular Curriculum Committee for CCLCM of CWRU
2006-2007 Tarazi Award Selection Committee
8. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 8
2006 Cardiovascular Medicine Outcomes Book Committee for 2006
2006 Selected ad hoc member of NIH Study Section on Heart Failure
Clinic Research Network
2007 ACC/Duke University Think Tank on Cardiovascular Imaging
2007- NHLBI and NIH search committees
Director, NHLBI Office of Communications
Director, NHLBI Office of Global Health (Chair)
Director, NHLBI Division for the Application of Research
Discoveries
Deputy Director, NHLBI Division of Blood Disease and
Resources
Deputy Director, NHLBI Division of Extramural Activities
Director, NIMH Division of Services and Interventions
Research
Director, NCI Division of Cancer Prevention
2008- American Heart Association Research Committee
2008-2010 ACC/AHA Committee on Cardiovascular Risk Assessment
2008-2010 ACC/AHA Writing Committee on CT coronary angiography
2009- Editorial Board, Annals of Internal Medicine
2009- NIH Coordinating Committee for Comparative Effectiveness
Research (Co-Chair since December, 2009)
2008- American Heart Association Quality of Care and Outcomes
Research (QCOR) Planning Committee
2010-2011 NIH CTSA IC Directors Advisory Committee
2010 US Department of Health and Human Services Comparative
Effectiveness Research Coordination and Implementation
Committee (CER-CIT)
9. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 9
2011- Patient Centered Outcomes Research Institute (PCORI)
Methodology Committee; Scientific Publications Working Group;
Program Evaluation Group; Scientific Oversight Committte
FDA Advisory Panels on Vytorin, Qnexa and CV Toxicity of GI
drugs
2012- Clinical Trials Transformation Initiative Executive Committee
2013- NIH Scientific Data Council
2014- NIH Co-Chair for President’s Precision Medicine Initiative
2015- NIH Committee on Efficient and Sustainable Funding Policies
MAJOR RESEARCH AND ACADEMIC INTERESTS:
1. Molecular biology and pharmacology, Rensselaer Polytechnic Institute
1979-1983
2. Cardiovascular epidemiology, Framingham Heart Study, 1990 - 1999
3. Exercise epidemiology, Cleveland Clinic Foundation, 1993 - 2007
4. Computerized medical record, Cleveland Clinic, 1994 - 2000
5. Clinical trials, 1997 – ongoing
6. Clinical cardiovascular epidemiology, 1993 – ongoing
7. Biostatistics, 2004-ongoing
8. Medical Editing (JAMA), 2000-2007
9. Comparative Effectiveness Research, 1990 –
10. Economics of Publicly Funded Biomedical Research, 2010 --
PRINCIPAL CLINICAL AND HOSPITAL SERVICE RESPONSIBILITIES:
1991-1993 Staff Cardiologist, Lahey Clinic Medical Center,
Burlington, MA
1993-2007 Staff Cardiologist, Cleveland Clinic Foundation,
Cleveland, Ohio
1997-2003 Co-Director, Cleveland Clinic Foundation Coronary Intensive Care
Unit
1997-2007 Vice Chair, Cleveland Clinic Foundation Institution Review Board
1999-2007 Medical Director, Cleveland Clinic Foundation Exercise Stress
Laboratory
10. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 10
TEACHING AND LECTURE EXPERIENCE (selected examples):
1988 Lecturer in electrocardiography, Massachusetts General
Hospital, Boston
Lecturer in "Introduction to Clinical Medicine," Harvard
Medical School and Massachusetts General Hospital, Boston
1993 Cardiology Grand Rounds, Cleveland Clinic Foundation,
"Hypertension and Left Ventricular Hypertrophy"
1994 Medical Grand Rounds, Cleveland Clinic Foundation, "Medicine
in Nazi Germany"
1994 Cleveland Clinic Health Talks, "Prevention and Regression of
Heart Disease"
Rainbow and Babies' Hospital Grand Rounds, "Medicine in Nazi
Germany"
1995 Cleveland Clinic Coronary Club, "The Epidemiology of Coronary
Artery Disease"
1993- Ernstene, Shirey, Consult and CCU Teaching Services, Cleveland
Clinic
1995 Cleveland Clinic CME Course in Cardiovascular Risk Factors,
"Left Ventricular Hypertrophy as a Risk Factor"
1996 MetroHealth Systems, Chronotropic Incompetence
Cleveland Clinic Cardiology Grand Rounds, Chronotropic
Incompetence
John Carroll University, Medicine in Nazi Germany
CNR, Pisa, Italy Exercise Hypertension
University of Heidelberg, Heidelberg, Germany and Katholic
University, Leuven, Belgium, Left Ventricular Hypertrophy
1997 Cleveland Clinic Ethics Committee Lessons from Nuremberg
11. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 11
Cleveland Clinic Internal Medicine Review Course, The
Electrocardiogram
American College of Cardiology Annual Scientific Sessions:
Info@ACC Enhancing Your Productivity: Evaluating Electronic
Medical Records for Clinical Practice
Cleveland Clinic Foundation Section of Heart Failure: Left
Ventricular Hypertrophy as a Cardiovascular Risk Factor: an
epidemiologic perspective
Walt Disney World and Cleveland Clinic Foundation Cholesterol
Summit, Directed Workshop on Early Detection of Coronary
Artery Disease.
Cleveland Clinic Division of Medicine, Course on Foundations of
Clinical Medicine, Dealing with Data.
Cardiology Grand Rounds, Cleveland Clinic Foundation, The
Electronic Medical Record.
1998 Cleveland Clinic Foundation Executive Health: Prevention of
Coronary Heart Disease.
American College of Cardiology, GUSTO IV Scientific
Investigators Committee
John Carol University, University Heights, OH AMedicine in Nazi
Germany.
Cleveland Clinic Department of Pulmonary Medicine,
Management of Acute Coronary Syndromes in the Intensive Care
Unit.
Cleveland Clinic Department of Pulmonary Medicine,
Management of Pericardial Disease in the Intensive Care Unit.
Marquette Annual ECG Analysis Seminar; Rehabilitating the
Exercise Electrocardiogram: Asking the Right Questions and
Getting the Right Answers.
Duke Clinical Research Institute, GUSTO IV Mini-symposium;
“Role of Glycoprotein IIb/IIIa Inhibitors in the Management of
Acute Coronary Syndromes.”
12. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 12
Cleveland Clinic Department of Cardiology: Introduction to
Biostatistics Series of lectures to Cardiology Fellows
Cleveland Clinic Division of Medicine, Journal Club Staff
Supervisor
1999 Cleveland Clinic Division of Medicine Grand Rounds:
Rehabilitating the Exercise Electrocardiogram.
Sid Peterson Hospital, Kerville, Texas Long Term Management
Strategies in Acute Coronary Syndromes: Risk Stratification of the
Patient Who has had Coronary Artery Bypass Grafting.
Cleveland Clinic Nursing Cardiac Care Symposium; Invited
Speaker – Strategies for the Prevention and Treatment of Sudden
Cardiac Death.
Mt. Sinai Hospital, Cleveland, Medical Grand Rounds;
Rehabilitating the Exercise Electrocardiogram.
Duluth Clinic Annual Cardiovascular Conference, Keynote
Speaker AUpdate in Heart Failure.
New York Hospital Cornell Medical Center Cardiology Grand
Rounds Chronotropic Incompetence: New Insights into an Old
Sign.
GUSTO IV Investigators Meeting: Introduction to the GUSTO IV
Acute Myocardial Infarction Trial: 2 hour lecture on the
background, rationale, and design of the trial as well as taking of
questions from regional investigators.
American Society of Echocardiography, Invited Speaker; Is
Nuclear Ever Better.
American Heart Association, Invited to Moderate How-to Session
“Timing of Post-MI Risk Stratification.”
Cleveland Clinic Foundation, Department of Rheumatology,
Cardiac Imaging in Chronic Disease.
Cleveland Clinic Foundation, Division of Surgery, Grand Rounds,
“Preoperative Cardiac Evaluation of the Patient Undergoing
Noncardiac Surgery: a Cardiologists Perspective.”
13. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 13
General Electric-Marquette Corporation, Milwaukee, Wisconsin:
New Developments in Exercise Testing.
2000 Cleveland Clinic Department of Hospital-Based Internal Medicine:
New Developments in Exercise Testing.
General Electric-Marquette Corporation Annual Meeting in Fort
Lauderdale, Florida: The Future of Exercise Testing.
American College of Cardiology Annual Meeting, Invited Speaker
at Symposium on Clinical Evaluation of the Patient Undergoing
Noncardiac Surgery.
Invited Speaker at Symposium: Exercise Testing in the New
Millennium, Featuring Who’s Who in Exercise Testing, organized
by Dr. Myrvin H. Ellestad and Dr. Ronald Startt-Selvester, on Use
of Chronotropic Response and Heart Rate Recovery in Exercise
Testing.
Cleveland Clinic Foundation Fellowship Lectures on Statistical
Review of Journal Articles.
Cleveland Clinic Foundation Symposium on Dimensions in
Cardiac Care, lecture on Beyond the ST Segment: New
Developments in Exercise Testing.
Cleveland Clinic Foundation Cardiovascular Board Review
Course; Clinical Epidemiology and Biostatistics: How to Interpret
a Clinical Research Study and Exercise ECG Stress Testing:
Diagnostic Utility and Prognostic Implications.
American Heart Association Cardiovascular Seminar on Novel
New Markers in the ECG Stress Test, invited lectures on
Chronotropic and Blood Pressure Responses.
2001 American College of Cardiology Symposium, invited lecture on
Post-MI Risk Stratification: The Role of Exercise
Electrocardiography.
American College of Cardiology Oral Presentation; Prognosis in
Patients with an Excellent Exercise Capacity.
American College of Cardiology Oral Presentation; Logical Data
Analysis for Assessment of Prognosis Among Patient Undergoing
14. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 14
Exercise Electrocardiography.
Cleveland Clinic Foundation Symposium on Preventing Heart
Disease; Resuscitating the Exercise Test.
American College of Sports Medicine, invited clinical lecture:
“Exercise Testing: A New Look at an Old Technology.”
American College of Sports Medicine invited lecturer at Clinical
Symposium on Detection of Silent Coronary Disease, “Use of
Chronotropic Response and Heart Rate Recovery.”
Cleveland Clinic Foundation Cardiology Review Course, “Clinical
Trials and Population Studies: Things You Must Know”
Cleveland Clinic Foundation Cardiology Review Course, “ECG
Stress Testing—Outdated or Up-to-date?”
Cleveland Clinic Foundation House Staff, “Introduction to Journal
Reading (2 lectures)”
2002 American College of Cardiology, Invited Symposium Lecture,
March, 2002: “Role of the Exercise ECG”
American College of Cardiology, Invited Lecture, March 2002:
“Maximizing the Use of Exercise Testing”
American College of Cardiology, Oral Presentation, March 2002:
“Ventricular Ectopic Activity Predicts Mortality When It Occurs
During Recovery, but Not Just During Exercise.”
Metro Health Center, Cleveland, Invited Lecture and Cardiology
Grand Rounds, April 2002: “The Exercise Test: Looking Beyond
the ST-Segment”
Office of Human Research Protection and Cleveland Clinic
Foundation Department of Bioethics Symposium on Research
Protection, Invited Lecture, May 2002: “Issues Involving
Authorship and Publication of Clinical Research”
Brigham and Women’s Hospital, Harvard Medical School,
Cardiology Grand Rounds, May 2002: “The Exercise Test:
Looking Beyond the ST-segment”
15. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 15
Maine Medical Center of Portland, Maine, Invited Lecture,
Visiting Professor, Cardiology Grand Rounds, May 2002: “The
Exercise Test: Looking Beyond the ST-Segment”
Maine Medical Center of Portland, Maine, Invited Lecture,
Visiting Professor, Fellows Noon Conference, May 2002: “Ethical
Issues Regarding Authorship”
Bikur Cholim Hospital, Jerusalem, Israel, June 2002: “The
Exercise Test: Looking Beyond the ST-Segment”
Hartford Hospital Department of Cardiovascular Medicine,
Visiting Professor and Invited Speaker, July 2002: “The Exercise
Test: Looking Beyond the ST-Segment”
American College of Cardiology, Yellowstone Summit, West
Yellowstone, Montana, August 2002, invited speaker: “Stress
Testing: Which Modality to Choose”
Cleveland Clinic Foundation Medical House Staff Journal Club,
September 2002: “Introduction to Clinical Journal Reading”
Cleveland Clinic Foundation Division of Medicine, September
2002: “Clinic Research Methods, Part I” (This was given twice,
under the auspices of Dr. James Stoller)
Cleveland Clinic Foundation Division of Medicine, September
2002: “Clinical Research Methods, Part II” (This lecture was
given twice, under the auspices of Dr. James Stoller)
Cleveland Clinic Foundation Cardiovascular Medicine Board
Review Course, September 2002: “Statistics for the Clinical
Cardiologist”
Cleveland Clinic Foundation Cardiovascular Medicine Board
Review Course, September 2002: “ECG Stress Testing---New
Approaches to an Old Modality”
Israeli Women’s Health Fellowship of the Jewish Community
16. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 16
Federation of Cleveland, October 2002: Seminar in “Topics on
Cardiovascular Disease in Women”
American College of Rheumatology, New Orleans, October 2002,
invited speaker: “Aspirin for Primary Prevention of
Cardiovascular Disease”
American Heart Association, November 2002: Moderator and
Invited Speaker “Using the Heart Rate to Improve Stress Test
Interpretation”
Tel HaShomer Medical Center and Tel Aviv University, December
2002: Visiting Professor and lecture on “Exercise Testing”
Looking Beyond the ST-Segment”
John Carroll University Freshman Program Speaker, December
2002: “Ethical Issues in Research”
2003 Cleveland Clinic Foundation Imaging Fellows Conference,
January Invited Speaker “Clinical Trials and Observational
Studies: Things You Must Know” January 2003
Biostats Seminar – Two fellowship lectures on “Clinical Research
Design” January 2003.
University of North Carolina at Chapel Hill, invited speaker, UNC
Heart Center Grand Rounds.
Cleveland Clinic Foundation Imaging Fellows Conference, Core
Fellows Lecture Series (Part I) Invited Speaker “Clinical Trials and
Observational Studies: Things You Must Know.”
Cleveland Clinic Foundation CTS Research Team Grand Rounds
Speaker, “Exercise Testing: Looking Beyond the ST Segment
February 2003.
Lakewood Hospital, Cleveland, Ohio Grand Rounds Speaker,
“Exercise Testing: Looking Beyond the ST Segment February
2003.
17. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 17
Case Western Reserve University School of Medicine Grand
Rounds, Invited Speaker, March 2003. “The Exercise Test:
Beyond the ST Segment.”
ACC Poster Session – “Heart Rate Recovery After Exercise and
Mortality with Exercise Testing”
ACC Meet the Experts – “Customizing the Image to the Patients:
AKA What Test is for Whom?”
ACC Oral Contributions – “Exercise Testing: Predicting
Mortality,” and “Association of Abnormal Heart Rate Recovery
and Chronotropic Incompetence with Obesity in a Healthy
Cohort.”
ACC Oral Contributions – “Stress Echocardiography: Ploughing
New Ground” and Survival Benefits of Early Myocardial
Revascularization after Stress Echocardiography: A Propensity
Analysis.”
ACC Oral Contribution – “The Old and the New” The ECT and
Novel Biomarkers in Acute Coronary Syndromes” and Does the
Presence of Electrocardiographic Left Ventricular Hypertrophy
Predict One-Year Mortality in Non-ST Elevation Acute Coronary
Syndromes.”
Cleveland Clinic Foundation Heart Failure Invited Speaker –
“Recent Innovations in Exercise Testing.”
Annual Meeting of the Israel Heart Society, Tel Aviv, Israel,
Invited Guest Lecturer, “Assessment of Prognostic Ambulatory
Patients with Congestive Heart Failure,” April 2003.
Cleveland Clinic Foundation Heart Failure Research Invited
Speaker, April 2003. “Exercise Testing: Beyond ST Segment”
Indiana University School of Medicine/Krannert Institute of
Cardiology, Cardiovascular Research Conference, Invited Speaker,
“Exercise Testing—Beyond the ST-Segment,” May 2003.
30th
International Congress on Electrocardiology, Helsinki,
18. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 18
Finland, Invited Speaker, “Recovery after Graded Exercise
Testing: An Under-appreciated Time of Great Prognostic Value,”
June 2003.
Invited Speaker “Internal Medicine Noon Conference” Cleveland
Clinic Foundation – “Introduction to Journal Club Part Deux.”
Residents Conference – “Clinical Epidemiology and Biostatistics
for the Clinical Practitioner.”
Invited Speaker – Cardiovascular Board Review Course – “An
Intensive Review of Cardiology” and “Statistics for the Clinical
Cardiologists” and “ECG Stress Testing – New Approach to Old
Modality,” InterContinental Hotel Amphitheater, CCF.
Residency Conference – “Clinical Epidemiology and Biostatistics
for the Clinical Practitioner.”
Invited Speaker – “Women’s Health Seminar on Cardiovascular
Disease” with visiting scholars and Israeli physicians, Jewish
Community Federation of Cleveland Women’s Health Program.
Cleveland Clinic Foundation Symposium on Men’s Health, Invited
Lecture on Screening for Coronary Artery Disease.”
Invited State-of-the-Art Speaker for the Annual Michael Pollock
Lecture on “Exercise Testing---Still the First Choice” at the
American Heart Association meeting on November 8, 2003,
Orlando, Florida.
2004
Visiting Professor and Invited Speaker – Tufts University, Boston,
Massachusetts – two lectures, one on “Methods in Clinical
Epidemiology” and one on “New Insights into Exercise Testing.”
Invited Speaker – Cardiovascular Board Review Coarse – “An
Intensive Review of Cardiology” and “Statistics for the Clinical
Cardiologists” and “ECG Stress Testing—New Approach to an
Old Modality,” InterContinental Hotel Amphitheater, Cleveland
Clinic Foundation.
19. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 19
ACC Scientific Sessions 2004 Program Presenter, “Gender
Differences in Diagnosis of Coronary Artery Disease”
ACC Scientific Sessions 2004 Program Presenter “Stress Testing:
Does It Have Any Role?”
5Th
Scientific Forum on Quality of Care and Outcomes Research in
Cardiology, Invited Lecturer, May 16, 2004, “How to Get Your
Outcomes Research Published.”
ACP (American College of Physicians) Two “Meet the Professor”
Sessions as an Invited Speaker – “Stress Testing: “When” “Which
One” “How Often”
Heart Failure Therapeutics Meeting, Guest Speaker, July 21, 2004,
“Metabolic Stress Testing.”
Journal Club Part I and Part II, Invited Speaker, August 9 and
September 15, 2004.
Mayo Clinic, Rochester Minnesota, Grand Rounds Speaker,
August 11, 2004, Two Lectures – Exercise Testing—Beyond the
ST-Segment.”
Symposium at AHA Physicians Outcomes Meeting and Invited
Speaker – “Publishing Outcomes Research” Omni Shoreham
Hotel, Washington, DC.
Cardiovascular Board Review Course, Cleveland Clinic
Foundation –Invited Speaker, “Statistics for the Clinical
Cardiologist” and “ECG Stress Testing—New Approach to an Old
Modality.”
Human in Medicine Series – Cleveland Clinic Foundation Noon
Conference – Invited Speaker, October 6, 2004, “Nazi Medicine.”
Men’s Health Summit, Cleveland Clinic Foundation Symposium,
October 14, 2004, Invited Speaker – “Treadmills and Scans:
Screening for Coronary Artery Disease.”
20. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 20
European Society of Cardiology Conference, Rome, Italy, October
17, 2004, Invited Speaker – “Roll of Exercise Testing After Acute
Coronary Syndrome.”
American Heart Association, Scientific Sessions 2004, November
8, 2004, Invited Speaker – “How to Interpret a Stress Test.”
Department of Internal Medicine Residency Program, Invited
Lecturer, December 1, 2004, - “Stress Testing.”
NIH Workshop – NHLBI Working Group on “Subclinical
Coronary Artery Disease: Functional Capacity as a Risk Marker,”
Bethesda, MD, July 13-14, 2004
Fellows’ Noon Conference, Invited Speaker, “Exercise Stress
Testing Part I,” July 29, 2004
Heart Failure Therapeutic Meeting – Invited Speaker – “Metabolic
Stress Testing,” July 21, 2004
Introduction to Journal Club Part I Noon Conference, Medical
House Staff, “Introduction to Journal Club.” August 8, 2004
Mayo Clinic Internal Medicine Grand Rounds, Rochester,
Minnesota, Invited Speaker, Two talks, “Exercise Testing:
Beyond the ST Segment, and “Ethical Issues in Medical
Authorship,” August 11, 2004
Nephrology Grand Rounds, Cleveland Clinic Foundation,
“Exercise Testing: Beyond the ST Segment,” August 27, 2004
Introduction to Journal Clubs Part II Noon Conference, Cleveland
Clinic Foundation, “Introduction to Journal Club,” September 14,
2004
5th
Annual Intensive Review in Cardiology, Cardiovascular Board
Review Course, Invited Speaker, two talks – “Statistics for the
Clinical Cardiologist” and “ECG Stress Testing –New Approach to
an Old Modality,” September 22, 2004
Cleveland Clinic Foundation Division of Medicine – Invited
Speaker, Cleveland Clinic Foundation, Humanities in Medicines
Series Noon Conference, “Nazi Medicine,” October 5, 2004
21. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 21
Men’s Health Summit, Cleveland Clinic Foundation, Invited
Speaker, “Treadmills and Scans” and “Screening for Coronary
Artery Disease, “October 14, 2004
European Society of Cardiology Working Group on Acute Cardiac
Care, Rome, Italy, Invited Speaker, “Risk Stratification and
Secondary Prevention in Post-Infarct Survivors in the Reperfusion
Era,” October 17, 2004
Cleveland Clinic Lerner College of Medicine of Case Western
Reserve University Invited Speaker – Medical School Dean’s
Dinner, “Heart Rate Recovery,” November 18, 2004
Internal Medicine Noon Conference, Internal Medicine Residency
Program, Cleveland Clinic Foundation, Invited Speaker, “Cardiac
Stress Testing.” December 1, 2004
2005
Cleveland Clinic Foundation, Department of Interventional
Cardiology, Invited Speaker, “Pre-Operative Cardiac Evaluation
with Special Emphasis on Ramifications of Recently Published
CARP Trial,” January 19, 2005
Boston Medical Center Cardiology Grand Rounds, Boston,
Massachusetts, Invited Speaker, “Risk Stratifying the Cardiac
Patient with Exercise Testing” February 9, 2005
American College of Cardiology Annual Scientific Session 2005,
Orlando, Florida, Co-Chair – “Meet the Experts:” – Medical
Manuscripts: Editors’ Perceptive,” March 08, 2005
Cleveland Clinic Foundation Internal Medicine Noon Conference,
Invited Speaker, “Pharmaceutical Industry and Medical Education:
A Free Lunch?” March 22, 2005
Cleveland Clinic Foundation, Department of Infectious Disease,
Retreat Presentation/Invited Speaker, “NIH Grants/External
Research Funding.” March 22, 2005
American College of Physicians Annual Session (Faculty Member)
and Invited Speaker, “Noninvasive Cardiac Imaging: Which Test
for Which Patient?” San Francisco, California, April 14-16, 2005
Cleveland Clinic Foundation, Department of Cardiac Surgery,
22. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 22
(CVIR) Invited Speaker, “Quantitative Electrocardiography and
Prognosis after Cardiac Surgery,” May 10, 2005.
Research Day 2005, Cleveland Clinic Foundation, Department of
Thoracic and Cardiovascular Surgery, Visiting Professor Lecture –
“Short- and Long-Term Outcomes of Cardiac Surgery for
Observant Jehovah’s Witnesses” – Sponsor for Dr. Mariano
Brizzio. June 10, 2005.
Solon Family Health Center/CCF Chagrin Falls Physician Staff,
Invited Speaker, “Non-invasive Cardiac Testing: Which Test for
Which Patient?” August 31, 2005
Course Director, Cleveland Clinic Lerner College of Medicine of
Case Western Reserve University, Clinical Epidemiology (45 hour
contact course for second year medical students), July-September,
2005
2005 Cardiovascular Board Review Course, invited speaker,
“Cardiac Testing” – “ETT”
Series of Cardiology Fellow Presentations in Epidemiology and
Biostatistics (2005 – ongoing)
Invited Speaker – CCF - An Intensive Review of Cardiology, (2
talks) “Exercise ECG Stress Testing: New Approach to an Old
Modality” and “Statistics for the Cardiologist.” September 21,
2005.
4th
International Meeting on Intensive Cardiac Care, Invited
Speaker, “The Significance of Troponin Elevation in Patients with
and without Renal Failure.” Tel Aviv, Israel September 27-29,
2005.
Acute Care Nurse Practitioner Students, Invited Speaker,
Cleveland Clinic, “Stress Testing.” November 1, 2005
Grand Round for Clinical Research at Cleveland Clinic – Invited
Speaker, “Investigator Responsibilities and Academic Freedom in
Clinical Research” Bunts Auditorium November 22, 2005.
Numerous television and radio interviews (Fox, Metro-News,
Men’s Health Magazine).
Gill Heart Institute, University of Kentucky, Grand Rounds
23. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 23
speaker at Fellow’s Conference. “Gill Seminar Series – IM and
Associated Stress Testing.” December 2, 2005.
2006
Invited guest lecturer on Cardiovascular Chronic Disease for
Seminar Course Lecture/Foundations in Research and Scholarship
in Class 483. February 1, 2006.
Invited Speaker – Clinical Ethics Symposium for First Year
Medical Student, Fire Restaurant, Shaker Heights, OH “Ethics in
Research,” March 5, 2006
Co-Chair (with Dr. Martha Gulati). “Meet the Experts Session,
Modern Exercise Test Interpretations.” American College of
Cardiology Annual Scientific Meeting, Atlanta, GA, March 13,
2006
Co-Chair. “Writing for Publication While in Training, Cardiac
Care Associates and Young Academic Cardiologists.” American
College of Cardiology Annual Scientific Meeting, Atlanta, GA
March 14, 2006.
Invited Speaker for Symposium - “How Editors Approach
Industry-Related Conflicts of Interest.” American College of
Cardiology Annual Scientific Meeting, Atlanta, GA March 14,
2006
Invited Speaker for Symposium – “Cardiologists on Trial:
Reflection on Credible Evidence.” American College of
Cardiology Annual Scientific Meeting, Atlanta, GA, March 14,
2006.
“Asymptomatic diabetics and metabolic syndrome: role of
imaging: - “Is there a role for the stress electrocardiogram?”
Invited Speaker, American College of Cardiology Annual
Scientific Meeting, Atlanta, GA, March 13, 2006.
“Tuesday Morning Vascular Medicine Conference” Lecturer-
Invited Speaker, “Pre-Operative Cardiovascular Risk Assessment
and Management for Vascular Surgery.” Cleveland Clinic, March
21, 2006
CME Symposium “Updates on Cardiovascular Medicine” New
Milford Hospital/New York Presbyterian Columbia and Cornell
University Medical Center, Invited Speaker, “Exercise and
24. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 24
Exercise Testing: not Enough Respect,” New Milford, CT, March
28, 2006.
Invited Speaker – Cleveland Clinic Cardiovascular Medicine
Athero-Thrombosis Group Meeting, “Autonomic Nervous System
Research in the Stress Lab,” March 2006.
Invited guest lecturer, Cleveland Clinic/Case Western Reserve
Acute Care Nurse Practitioner Class – Stress talk, “Specialty
Assessment and Diagnostics.” April 4, 2006
Baystate Medical Center, Plotkin Conference, Invited Speaker at
the “Log Cabin Conference Center,” “Noninvasive Cardiac
Testing: Which Test for Each Patient?” Holyoke, MA. April 7,
2006
Invited Speaker – Clinical Trials Course for the Department of
Quantitative Health Sciences, “Clinical Trials from Viewpoint of
Journal Editor,” Cleveland Clinic, May 4, 2006.
7th
American Heart Association Forum on Quality of Care and
Outcomes in CVD and Stroke, Washington, DC, Invited Speaker,
“Writing for Medical Journals: A Session with the Editors,”
“Publication in JAMA: An Editor’s Perspective.” May 8, 2006.
Krannert Institute of Cardiology of Indiana University, Invited
Speaker, Indianapolis, IN, Grand Rounds. “Ethical Issues in
Biomedical Authorship” and “Author Responsibilities and
Academic Freedom: an Editor’s Perspective.” May 9, 2006.
University of Alberta, Edmonton Canada, Invited Distinguished
Speaker/Grand Rounds, “Contemporary Ethical Issues in
Biomedical Authorship” May 17, 2006.
Spring Ohio College of Clinical Pharmacy Meeting, Cleveland,
OH, Invited Speaker – Keynote Address, “Conflict of Interest:
Perspectives of a Physician and a Medical Editor,” May, 24, 2006.
Invited Speaker – Cleveland Clinic Intensive Review in Internal
Medicine, “Board Simulation in Biostatistics” Intercontinental
Hotel, Cleveland Clinic. June 13, 2006.
Invited Speaker – 2006 Clinical Research Grand Rounds,
“Designing Clinical Trials.” Center for Clinical Trials, Cleveland
Clinic, June 27, 2006.
25. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 25
Conflict of Interest Concerns in Biostatistical Work, invited as
“Special Contributed Panel” member, Montreal Canada, July 20,
2006.
IBC Meeting, invited speaker, “Editors’ Approach to Industry
Related Conflict of Interest: JAMA, July 26, 2006, Montreal
Canada.
The American College of Cardiology Foundation, Cardiovascular
Board Review, invited speaker/faculty. “Exercise Treadmill
Testing.” September 7, 2006, Dallas, TX
Case Western Reserve EPBI 510 Class Health Disparities Graduate
Course, invited speaker, “SES and Cardiac Parameters.”
September 11, 2006.
Inventors’ Forum on Managing Innovation/COI 2006-2007,
invited speaker, “Do’s and Don’ts of IRB.” September 14, 2006.
Beterson 16-Year Long-Term Followup Study - Mortality in MS
Workshop, invited speaker for meeting on Survival in MS.
“Exercise Treadmill Testing.” September 17, 2006, New York, NY
Annual Intensive Review of Cardiology, Cleveland Clinic, invited
speaker, 2 talks, “Electrocardiogram Stress Testing – A New
Approach to an Old Modality” and “Statistics for the
Cardiologist.” September 20, 2006.
CCLCM invited speaker for medical student class. “Authorship,”
September 22, 2006.
American Association for Thoracic Surgery and Directors of the
Cleveland Clinic Kaufman Center for Heart Failure 21st
Century
21st
Century Treatment of Heart Failure: Synchronizing Surgical
and Medical therapies for Better Outcomes, Invited Speaker.
“Predicting outcomes in patients with heart failure: Clinical
characteristics, peptides perfusion and function. October 20, 2006
“A New Dimension in Leadership: Emotional Intelligence”
Workshop, Cleveland Clinic Center for Leadership and Learning,
Cleveland OH, October 23, 2006
American Association for Thoracic Surgery – 21st
Century
Treatment of Heart Failure: Synchronizing Surgical and Medical
26. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 26
Therapies for Better Outcomes - Invited Speaker - Predicting
Outcomes in Patients with Heart Failure: clinical Characteristics,
peptides, perfusion and Function.” MBNA Conference Center,
Cleveland Clinic InterContinental Hotel, Cleveland Ohio
Acute Cardiac Care Congress 2006, European Cardiac Society and
Israel Heart Association, Czech Republic, October 21-24, 2006,
Scientific Committee and Invited Speaker.
Swedish Society of Clinical Physiology – Invited Speaker –
“Torgny Sjostrand Honorary Lecture in Clinical Physiology,
Annual Meeting of the Swedish Society of Medicine, Goteborg,
Sweden. “Exercise Testing—An Integrated Physiological
Approach of High Prognostic Value in Clinical Medicine” and
“Exercise Testing and Autonomic Function in Cardiovascular
Disease.” November 30, 2006.
The Department of Bioethics, invited guest lecturer,
“Contemporary Ethical Issues in Biomedical Authorship: An
Editor’s Perspective.” Cleveland Clinic. December 5, 2006.
Cerebrovascular Research invited speaker. “Introduction to
Diagnostic Tests.” December 14, 2006.
2007
Cleveland Clinic, Division of Medicine Grand Rounds Speaker.
“Cardiovascular Medicine Department Update.” January 4, 2007.
MetroHealth Heart & Vascular Center Grand Rounds, invited
speaker, “Ethical Issues in Biomedical Authorship, January 10,
2007.
Invited Clinical Trials Course Speaker (with Drs. Gerald Beck and
A. Michael Lincoff) – Cleveland Clinic. “Authorship and Clinical
Trials.” January 11, 2007.
Framingham Heart Study, Invited speaker, “Advances in Exercise
Testing,” Framingham, MA. February 8, 2007.
Planning and Implementation of Performance Management
Systems in Healthcare Organizations, Weatherhead Executive
Education, Weatherhead School of Management, Case Western
Reserve University. March 9, 2007.
27. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 27
Keynote Speaker, Cleveland Clinic Lerner College of Medicine,
March 22, 2007.
Invited Speaker and Faculty Member – American College of
Physicians, “Meet the Professor Courses,” and “Noninvasive
Testing for Coronary Artery Disease.” San Diego, CA April 19,
2007.
ACC 56th
Annual Scientific Session – invited speaker and faculty.
Four talks: “How to Get Your Paper Published,” “Screening for
Coronary Artery Disease in High-risk Asymptomatic Patients,”
“Modern Exercise Testing Interpretation: An Oxymoron,” and
“Meet Your Medical Editors.” March 24-27, 2007
Invited “Noon Conference” Speaker – Internal Medicine,
Cleveland Clinic. “Update on Stress Testing – Exercise Treadmill
Testing.” April 23, 2007.
Various radio and television interviews, HealthNews, Heart
Advisor, BBC. Fox, The Heart.Org., Cleveland Clinic
ACC Think Tank on Cardiovascular Imaging, presentation on new
research paradigms, Tyson’s Corner, VA, October, 2007
Invited plenary session comment on CORE-64 Trial, American
Heart Association Scientific Sessions, November 4, 2007, Orlando,
FL
2008 (selected)
“Data Primarily Collected for New Insights.” February 28, 2008
Institute of Medicine Roundtable on Evidence-Based Medicine
Washington, DC
Washington Business & Health CEO Summit in conjunction with
the University of Washington, Seattle, WA, March 26, 2008.
“Prevention of Coronary Artery Disease.”
Visiting Professor, Duke University and Duke Clinical Research
Institute, Durham, NC, April 13-15, 2008. Three lectures:
“Evidence-Based Overview of Noninvasive Cardiac Testing,”
“Novel Statistical Approaches for Analyzing Large Databases,”
and “Ethics of Biomedical Authorship”
Visiting Professor, Boston University, Boston, MA, May 21-22,
28. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 28
2008. “Evidence-Based Overview of Noninvasive Cardiac
Testing.”
Baaken Heart-Brain Summit, Cleveland Clinic, Cleveland, OH,
June 3, 2008. “Vagal Tone and Outcomes in Patients with
Cardiovascular Disease.”
NIH OBSSR Summer Course in Clinical Trials, Airlie, VA. July
16, 2008. Featured lecture: “Ethical Issues in Biomedical
Authorship and Peer Review.”
Ancel Keys Memorial Lecture of the American Heart Association,
New Orlean, LA, November 10, 2008. “Discarding Logic.”
2009 (selected)
Visiting Professor, Indiana University, Indianapolis, Indianna.
February 3, 2009. “A Research Agenda for Cardiovascular
Disease: Crossroads of Evidence and Public Policy.”
Cleveland Clinic Cardiovascular Summit, Cleveland, Ohio. June
3, 2009. Two lectures: “Does Non-invasive Imaging Prevent
Death,” and “Does Exercise Help Patients with Heart Failure?”
NIH OBSSR Summer Course in Clinical Trials, Airlie, VA. July
16, 2008. Featured lecture: “Ethical Issues in Biomedical
Authorship and Peer Review.”
American Heart Association Basic Science Conference, July 21,
2009, Las Vegas, NV. “NHLBI Research Funding and Update on
Priorities.”
Visiting Professor, Christiana Medical Center, July 22, 2009,
Newark, DE. “Reflections on Comparative Effectiveness.”
World Hemophilia Federation, September 24, 2009, Montreal,
Quebec, Canada. “Economics and Comparative Effectiveness:
Threats to Care?”
Invited Lecturer, Institute of Medicine Forum on Drug Discovery,
Development, and Translation, Transforming Clinical Trials in the
United States, October 7, 2009, Washington, DC. “Clinical
Research in Acute and Chronic Life-threatening Conditions: A
Government Perspective.”
29. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 29
Visiting Professor, Henry Ford Hospital, October 13, 2009,
Detroit, MI. “Reflections on Comparative Effectiveness.”
Invited Lecturer, Personalized Medicine Coalition and the National
Pharmaceutical Council, October 28, 2009, Arlington, VA.
“Thoughts about Personalized Medicine and Comparative
Effectiveness Research.”
American Association of Medical Colleges Convention, November
9, 2009, Boston, MA. “Comparative Effectiveness: Views from
the National Institutes of Health.”
Moderator, Plenary Session, American Heart Association Annual
Scientific Sessions, November 16, 2009, Orlando, FLA. “The
Challenges of Imaging Wisely and Responsibly.”
Sixth Annual Global Cardiovascular Clinical Trialists’ Forum,
December 2-5, 2009, Paris, France, and Luxembourg City,
Luxembourg. Two talks: “Comparative Effectiveness Research
and Pragmatic Trials,” and “Nonindustry Sponsored Trials and the
Role of NHLBI and EU Public Institutions.”
US Critical Illness and Clinical Trials Group, December 9, 2009,
Bethesda, MD. “Comparative Effectiveness Research: NIH
Perspectives.”
2010 (selected)
NCI ARRA Comparative Effectiveness Symposium, January 5,
2010, Bethesda, MD. “The 2010 NIH Vision for Comparative
Effectiveness Research.”
Invited Guest Lecturer, Centers for Medicare and Medicaid
Services, January 13, 2010, Baltimore, MD. “Evidence-
Development: Perspectives from the NIH”
Visiting Professor, Massachusetts General Hospital, March 3,
2010, Boston, MA. “Comparative Effectiveness Research One
Year Later.”
Keynote Speaker, 3rd
Annual NIH Conference on Dissemination
and Implementation Research, March 15, 2010, Bethesda, MD.
“Where Does Comparative Effectiveness Research Fit in the
Domains of Dissemination and Implementation.”
30. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 30
Invited Speaker, American College of Cardiology Annual
Sessions, March 16, 2010, Atlanta, GA. “Cardiovascular Risk in
Asymptomatic Adults, Use of Noninvasive Tests, ECG, IMT,
CAC.”
Invited Meet-the-Expert Speaker, American College of Physicians
Annual Meeting, April 23, 2010, Toronto, Ontario, Canada.
“Noninvasive Cardiac Imaging, Which Test for Which Patient?”
Invited Panelist, University of Pennsylvania R13 Special
Conference, April 27, 2010, Philadelphia, PA. “Statistical Issues
in Comparative Effectiveness Research.”
Keynote Speaker, Delaware Health Alliance Annual Meeting, May
4, 2010, Newark, DE. “Comparative Effectiveness Research: One
Year Later.”
Invited Symposium Speaker, American Thoracic Society Annual
Scientific Meeting, May 17, 2010, New Orleans, LA.
“Comparative Effectiveness Research at NHLBI: Opportunities
and Challenges.”
Sharma Visiting Professor, Mt Sinai Medical Center
Cardiovascular Institute, May 24, 2010, New York City, NY.
Invited Speaker, NHLBI Public Interest Organizations Annual
Meeting, May 25, 2010, Bethesda, MD. “Cardiovascular
Highlights from the American Recovery and Reinvestment Act.”
Invited Speaker for Highlighted Symposium, American College of
Sports Medicine Annual Scientific Meeting, June 3, 2010,
Baltimore, MD. “Autonomic Function and Outcomes in Patients
with Cardiovascular Disease.”
Invited Speaker for Symposium, American Health Insurance Plans
Institute Annual Meeting, June 10, 2010, Las Vegas, NV. “Using
Science to Improve the Nation’s Health System: The Case of
Comparative Effectiveness Research.”
Invited Speaker for Lewin Group Symposium on Responding to
the National Comparative Effectiveness Research Agenda:
Evolving Data Sources and Analytics, June 15, 2010, Washington,
DC. “What are the Limits of Randomized Clinical Trials: Then
What?”
31. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 31
Invited Speaker and Panelist for National Pharmaceutical Council
on Shaping Convergent Strategies for Comparative Effectiveness
Research, June 24, 2010, Washington, DC. “The Patient-Centered
Outcomes Research Institute (PCORI).”
Invited Speaker for NHLBI Workshop on Comparative
Effectiveness, July 13, 2010, Bethesda, MD. “Comparative
Effectiveness Research at NHLBI: Opportunities and Challenges.”
Invited Speaker, Market Access World, October 6, 2010,
Washington DC. “How is the stimulus being invested by NIH –
Timelines, Implemention, Pathway, Structure?”
Invited Keynote Speaker, American Geriatric Society CER
conference, November 2, 2010, Bethesda, MD.
Invited Speaker, CBI 4th
Annual CER Summit, Thursday,
November 18, 2010, Philadephia, PA.
Invited Keynote Speaker, NIH CTSA Consortium CER
Symposium, December 1, 2010, Bethesda, MD. “How Can
CTSAs and External Partners Collaborate to Support a National
CER Agenda?”
Invited Visiting Professor and Grand Rounds Speaker, Cleveland
Clinic Heart and Vascular Institute, December 3, 2010, Cleveland,
OH. “Cardiovascular Comparative Effectiveness Research in the
Era of Health Care Reform.”
Invited Speaker, Heart Rhythm Society Research Meeting,
December 15, 2010, Washington, DC.
Grand Rounds Speaker and Visiting Professor, George Washington
University Department of Cardiology, December 16, 2010,
Washington, DC. “A Philosophy of Non-Invasive Diagnostic
Testing”
Grand Rounds Speaker, George Washington University
Department of Medicine, December 17, 2010, Washington, DC.
“Comparative Effectiveness Research: Two Years Later.”
2011 (selected)
Invited Plenary Speaker, International Society for Cardiac
Magnetic Resonance, February 4, 2011, Nice, France.
32. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 32
“Cardiovascular Imaging: Why Randomized Trials are Needed.”
Invited Grand Rounds Speaker and Visiting Professor, Oregon
Health Sciences University, February 8, 2011, Portland Oregon.
Two lectures, one on “Ethics in Authorship and Peer Review” and
one on “The Case for Comparative Effectiveness Research.”
Invited Speaker and Visiting Professor, Rockefeller University,
February 16, 2011, New York, NY. “The Case for Comparative
Effectiveness Research.”
Invited Speaker, Late Phase Drug Development Symposium,
March 23, 2011, Boston, MA. “The Case for Comparative
Effectiveness Research.”
Invited Speaker, American Occupational Health Conference,
March 29, 2011, Boston, MA. “The Case for Comparative
Effectiveness Research.”
Invited Speaker, American College of Cardiology, April 3, 2011,
New Orleans, LA. “What Parameters Should be Used to Assess
Improved Patient Outcomes of Cardiovascular Imaging?”
Invited Speaker, NHLBI WHI Investigators Meeting, May 5, 2011,
Seattle, WA. “The Case for Comparative Effectiveness Research.”
Invited Speaker, Harvard Medical School Post-Approval Summit,
May 11, 2011, Boston, MA. “The Case for Comparative
Effectiveness Research.”
Invited Grand Rounds Speaker, Indiana University Krannert
Institute, May 31, 2011, Indianapolis, IN. “The Economics of
Cardiovascular Research.”
Invited Speaker, NCCAM Advisory Council Meeting, June 3,
2011, Bethesda, MD. “The Case for Comparative Effectiveness
Research.”
Invited Speaker, Drug Information Association (DIA) Meeting,
June 20, 2011, Chicago, IL. “Comparative Effectiveness and
Health Technology Assessment: How NIH is Addressing the
Challenge.”
Invited Speaker, National Health Leadership Council Forum and
National Business Coalition on Health, June 22, 2011,
33. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 33
Minneapolis, MN. “Science for the Benefit of the Nation’s Health
Care: The Case for Comparative Effectiveness Research.”
Invited Speaker, North American Conference of Epidemiology,
June 23, 2011, Montreal, Quebec, CA. “NIH Perspective:
Observations (on Observations) and Experiments.”
Invited Speaker, National Institute on Minority and Health
Disparities, Special Course on Integrating Principles of Science,
Practice, and Policy in Health Disparities Research, June 29, 2011,
Bethesda, MD. “Comparative Effectiveness Research:
Implications for Science, Practice, and Policy.”
Invited speaker, Office of Surveillance and Epidemiology, Center
for Drug Evaluation and Research, US Food and Drug
Administration, July 6, 2011, White Oak, MD. “Comparative
Effectiveness Research: Implications for Science, Practice, and
Policy.”
Invited speaker, NHLBI Workshop on Heart Failure Prevention,
July 14, 2011, Bethesda, MD. “NHLBI Perspective: Thoughts
about Inputs and Outputs.”
Invited speaker, Center for Medical Technology and Policy
(CMTP) CER Institute, July 25, 2011, Santa Fe, NM.
“Comparative Effectiveness Research: Federal NIH Perspectives
on Science, Practice, and Policy.”
Invited speaker, NHLBI Office of Administrate Management
Seminar Series presentation, August 17, 2011, Bethesda, MD.
“What’s the Story Behind the Explosion of Diagnostic Tests and
Imaging?”
Invited Keynote speaker, American Heart Association
Pharmaceutical Roundtable Outcomes Center Steering Committee
Annual Meeting, September 12, 2011, Palo Alto, CA.
“Cardiovascular Outcomes Research: Going Forward.”
Invited speaker, CBI 14th
Registries and Post-Approval Studies
Congress, September 21, 2011, Philadelphia, PA. “NIH Address:
Advancing Comparative Effectiveness Research through the
Patient-Centered Outcomes Research Institute (PCORI).”
Visiting Professor and invited speaker for Medical Grand Rounds,
University of Wisconsin, September 23, 2011, Madison, WI.
34. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 34
“Comparative Effectiveness Research: Implications for Science,
Practice, and Policy.”
Invited guest speaker, National Institute of Arthritis and
Musculoskeletal Diseases (NIAMS) Advisory Council Meeting,
September 27, 2011, Bethesda, MD. “Science to Improve the
Nation’s Health Care: The Case for Comparative Effectiveness
Research.”
Invited Keynote speaker, Market Access World USA 2011,
October 5, 2011, Washington DC. “Comparative Effectiveness
Research: Updates from the NIH.”
Invited speaker, Duke University Think Tank on Rescuing Clinical
Trials, October 6, 2011, Tysons Corner, VA. “Patient and
Physician Perceptions on Clinical Research and Trials,” and “NIH
and VA investment in funding trials and funding research
networks: is it helping, and is it paying off?”
Invited Keynote speaker, 3rd
Annual CER Summit, October 12,
2011, Washington DC. “The Role of the NIH in Comparative
Effectiveness Research.”
Invited speaker, Institute of Medicine Forum on Drug Discovery,
November 7, 2011, Washington DC. “Developing a Robust
Clinical Trials Workforce.”
Invited speaker and Distinguished Visiting Professor, Cedars-Sinai
Heart Institute (UCLA), November 8, 2011, Los Angeles, CA.
“The Case for Comparative Effectiveness Research.”
Invited speaker, American College of Cardiology Cardiovascular
Symposium, November 13, 2011, Orlando, Fla. “Comparative
Effectiveness in Heart Failure: Are Randomized Trials
Necessary?”
Invited guest speaker, FAES Public Health, November 16, 2011,
Bethesda, MD. “The Case for Comparative Effectiveness
Research.”
Invited speaker, NIH Centers for Population Health and Health
Disparities, November 29, 2011, Bethesda, MD. “Biomedical
Research: How Do We Know We are on Track?”
Invited speaker, Global Cardiovascular Clinical Trialists Forum,
35. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 35
December 5, 2011, Paris, France. “New Designs and Paradigms
for Large Simple Trials.”
Invited speaker, Gilbert Beebe Symposium on Tracking Radiation
Exposure from Medical Diagnostic Procedures, National
Academies of Science, December 8, 2011, Washington, DC. “The
Physician’s Perspective on What to Report.”
2012 (selected)
Invited speaker, Health Sector Management Program of the Fuqua
School of Business and Duke University, January 11, 2012,
Bethesda, MD. “Biomedical Research: How Do We Know we are
on Track?”
Invited speaker and Visiting Professor, Cleveland MetroHealth
Cardiology Grand Rounds, February 1, 2012, Cleveland, OH.
“National Policy Issues Surrounding Comparative Effectiveness
Research.”
Invited speaker, Cleveland MetroHealth Medical Grand Rounds,
February 2, 2012, Cleveland, OH. “Evaluation and Screening of
Asymptomatic People.”
Invited speaker and Visiting Professor, Yale University School of
Medicine Cardiology Grand Rounds, February 7, 2012, New
Haven, CT. “Cardiovascular Outcomes Research Going Forward.”
Invited speaker, Cleveland Clinic Medical Grand Rounds,
February 23, 2012, Cleveland, OH. “A National Agenda for
Comparative Effectiveness Research: PCORI and Beyond.”
Keynote speaker, Washington University Symposium on
Comparative Effectiveness and Shared Decision Making, March
13, 2012, St. Louis, MO. “Challenges and Successes in CER
Implementation: Examples from Pragmatic Trials.”
Invited speaker for cardiovascular symposium, American College
of Cardiology, March 25, 2012, Chicago, IL. “The Year in
Review: Diagnostic Testing.”
Invited speaker, American College of Cardiology, March 25, 2012,
Chicago, IL. “Risk Stratification: Looking Beyond the ECG
During Stress Testing.”
36. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 36
Invited speaker, ExL Pharma Symposium, April 2, 2012,
Washington, DC. “NIH’s Expectations for Using CER Evidence
for Commercialization.”
Invited speaker, University of Missouri at Kansas City, April 17,
2012, Kansas City, MO. “A National Agenda for Comparative
Effectiveness Research: PCORI and Beyond.”
Keynote Speaker, Cardiovascular Molecular Imaging Symposium,
Society of Nuclear Medicine, April 19, 2012, Bethesda, MD.
“Comparative Effectiveness: Where Does Molecular Imaging Fit
in Relation to Biomarkers?”
Invited speaker, Inova Summit, April 27, 2012, Tysons Corner,
VA. “Appropriateness of Imaging: The Use and Abuse of
Noninvasive Imaging.”
Invited speaker, Christiana Care’s Value Symposium, April 30,
2012, Newark, DE. “Creating Value Through Science.”
Invited speaker, Institute of Medicine Clinical Effectiveness
Research Innovation Collaborative of the IOM Roundtable on
Value and Science-Driven Health Care, May 8, 2012, Washington,
DC. “Implications of the Digital Infrastructure for Clinical
Research: Simplified Trial Design.”
Invited Plenary Speaker, International Research Congress on
Integrative Medicine and Health, May 17, 2012, Portland, OR.
“Comparative Effectiveness Research: Implications for Practice
and Policy.”
Keynote Speaker, Cardiovascular Research Roadmap Symposium,
Ohio State University, June 1, 2012, Columbus, OH. “Biomedical
Research: How Do We Know We are on Track?”
Invited speaker, Cardiac Safety Research Consortium Thinktank,
FDA, June 4, 2012, White Oak, MD. “Efficient Electronic
Infrastructure: an NIH View.”
Invited speaker, NHLBI Advisory Council, June 13, 2012,
Bethesda, MD. “Biomedical Research: How Do We Know We are
on Track?”
Keynote speaker, Center for Business Intelligence Forum on
Investigator-initiated Research Studies and Grants, June 14, 2012,
37. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 37
Philadelphia, PA. “NIH Perspectives on Investigator-Initiated
Clinical Research.”
Invited speaker, American Society for Echocardiography, July 3,
2012, National Harbor, Maryland. “Comparative Effectiveness
Trials for Imaging in Coronary Artery Disease: Is there Evidence?”
Invited speaker, NHLBI Division of Intramural Research Grand
Rounds, July 2012, Bethesda, MD. “Two Case Studies of Exercise
Testing with NIH Patients”
Invited Keynote Speaker, 12th
Annual NIH OBSSR Summer Institute
on Randomized Behavioral Clinical Trials, July 2012, Airlie
Conference Center, Warrenton, VA. “Biomedical Research: How
Do We Know We Are On Track?”
Invited Speaker, New York University School of Medicine
Cardiology Grand Rounds, September 7, 2012, New York City, NY.
“Biomedical Research: How Do We Know We are on Track?”
Invited Speaker, Northwestern University Conference on Path to
Improved Risk Stratification in Sudden Cardiac Death, September
2012, Chicago, IL. “Funding Risk Stratification Research –
Addressing the Challenges - NIH perspective”
Invited speaker, NHLBI Board of External Experts Semi-Annual
Meeting, October 10, 2012, Rockville, MD. “Transformative
Change in Epidemiology.”
Invited Speaker, Cleveland Clinic Foundation Heart Failure
Summit, October 17, 2012, Cleveland OH. “Comparative
Effectiveness Research in Heart Failure.”
Invited Speaker, US Conference on Rare Diseases and Orphan
Products, October 22, 2012, Washington, DC. “Comparative
Effectiveness Research in Rare Diseases.”
Invited Opening Address, NIH Common Fund Health Care
Systems Collaboratory Steering Committee Inaugural Meeting,
October 26, 2012, Bethesda, MD. “Pragmatic Trials: Back into a
Future Disruptive Technology.”
Invited Speaker, Summit on Eliminating Health Disparities,
November 1, 2012, National Harbor, MD. “NIH Patient Centered
Outcomes and Effectiveness Research.”
38. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 38
Invited Keynote Speaker, National Comparative Effectiveness
Research Summit, November 5, 2012, Washington, DC. “Current
CER Landscape and NIH Activities”
Invited Speaker, CBI Conference November 16, 2012,
Philadelphia, PA. “Government-Funded Research on Patient-
Reported Outcomes.”
Invited Opening Speaker, Institute of Medicine Workshop,
November 26, 2012, Washington, DC. “A Vision of Large Simple
Trials in a Learning Health Care System.”
Invited Speaker, Cardiovascular Clinical Trialists Forum,
December 3, 2012, Paris, France. “Registries and Post-Market
Surveillance as Complements to Randomized Trials.”
Invited Speaker, FDA Symposium on Cardiac Safety, December
10, 2012, White Oak, MD. “Current Heuristic Approaches.”
Invited Speaker, NHLBI Centers for Cardiovascular Outcomes
Research Steering Committee Meeting, December 11, 2012,
Arlington, VA. “Large Simple Trials in Learning Health Care
Systems.”
2013 (selected)
January 28, 2013: Columbia University Dean’s Symposium
Keynote-equivalent Presentation on Funding Research in Dynamic
and Disruptive Fiscal Times, New York, NY
January 29, 2013: DHHS ASPE Invited Presentation on NIH Role
in Comparative Effectiveness Research, Humphrey Building,
Washington, DC
February 7, 2013: DCVS Clinical Trials Group on Our Innovator’s
Dilemma, Rockville, MD
April 13, 2013: American College of Physicians Annual Scientific
Meeting Meet The Professor Symposium sole presenter on
Screening for Coronary Artery Disease, San Francisco, CA
39. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 39
April 17, 2013: NHLBI BEE Presentation on Transforming
Epidemiology, Rockville, MD
May 2, 2013: NIDDK Presentation on Transforming Clinical
Trials, Bethesda, MD
May 9, 2013: Virtual Symposium on Radiation Safety in
Computed Tomography Presentation on Evidence Gap Problem,
San Francisco, CA
May 9, 2013: Virtual Symposium on Radiation Safety in
Computed Tomography Presentation on Problems due to
Downstream Procedures, San Francisco, CA
May 13, 2013: Clinical Trials Transformation Initiative
Presentation on Perspectives on Large, Simple Trials, Rockville,
MD
July 21, 2013: OBSSR Course on Randomized Trials, Keynote
address on “Our Innovator’s Dilemma,” Airlie Conference Center,
Warrenton, VA
May 15, 2013 (in absentia, talk given by Larry Fine): NHLBI
Leadership Retreat Presentation on Map of Implementation
Research at NHLBI, Bethesda, MD
May 28, 2013: DCVS Journal Club presentation on angioedema,
mini-Sentinel
June 5, 2013: NCI Brain Tumor Epidemiology Consortium,
Keynote address on Transforming Epidemiology, Chicago, IL
June 19, 2013: NHLBAC Presentation on Transforming
Epidemiology, Bethesda, MD
June 19, 2013: NHLBAC Presentation on Guidelines, Bethesda,
MD
40. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 40
June 23, 2013: Academy Health Presentation on NHLBI Support
of Health Services Research, Baltimore, MD
June 27, 2013: National Pharmaceutical Council ISPOR
Roundtable on Observational Studies and Guidelines, Washington,
DC
July 17, 2013: NIH Office of Science Policy Program and
Evalaution Committee Presentation on Patient-Centered Outcomes
Research Institute (PCORI) activities
July 21, 2013: OBSSR Course on Randomized Trials, Keynote
address on “Our Innovator’s Dilemma,” Airlie Conference Center,
Warrenton, VA
July 22, 2013: NHLBI Annual K-awardees Meeting, invited talk
on “NHLBI Research: A Vision of the Future,” Natcher
Conference Center, Bethesda, MD
August 2, 2013: NHLBI Heart Failure Network Strategy Planning
Meeting, invited opening talk on “NHLBI Perspectivies: Turn the
Curve,” Bethesda, MD
August 20, 2013: Stanford University School of Medicine
Cardiovascular Grand Rounds on “Economic Perspectives on
Government-Sponsored Research,” Palo Alto, CA
August 21, 2013: Stanford University School of Medicine
Department of Medicine Grand Rounds on “Transforming Clinical
Trials in an Era of Big Data and Small Budgets,” Palo Alto, CA
November 5, 2013: Invited Faculty, NIH PBHL 571-NIH Graduate
School of Public Health, “The Case for Comparative Effectiveness
Research,” Bethesda, MD
November 17, 2013: Invited Special Lecture, American Heart
Association Annual Scientific Sessions, “A Tribute to Dr. Sonia
Skarlatos,” Dallas, TX
41. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 41
November 19, 2013: Invited Speaker, American Heart Association
Annual Scientific Sessions, Cardiovascular Seminar CVS.809ic,
“Cardiorespiratory Fitness as a Therapeutic Target,” Dallas, TX
November 18, 2013: Invited Speaker, American Heart Association
Annual Scientific Sessions, Cardiovascular Seminar CVS.213,
“Practical Trials in Outcome Science,” Dallas, TX
November 21, 2013: Invited Speaker, GenTAC Steering
Committee Meeting, “Let Me Tell You Two Stories: Perspectives
in a Time of Big Data and Small Budgets,” Bethesda, MD
December 6, 2013: Invited Webinar Presentation, NHLBI BEE
Council Working Group on Epidemiology and Population
Sciences, “Thoughts about NHLBI and Epidemiology: ‘Big
Picture’ Fiscal Challenges,” Bethesda, MD
2014 (Selected):
February 6, 2014: Invited Speaker and Visiting Professor,
University of Pennsylvania Perelman School of Medicine,
“Cardiology Grand Rounds: Supporting Biomedical Research – An
Economic Perspective,” Philadelphia, PA
February 7, 2014: Invited Speaker, NHLBI MESA Steering
Committee, “Thoughts about NHLBI and 21st
Century
Epidemiology – ‘Big Picture’ Challenges,” Washington, DC
February 20, 2014: Invited Speaker, ISCTM 10th
Annual Meeting,
“The Necessity for Clinical Trials Innovation: Making it Work at
the National Heart, Lung, and Blood Institute,” Washington, DC
March 13, 2014: Invited Speaker, NIH IC Directors’ Meeting,
“Perspectives from the NHLBI on Portfolio Prediction and
Performance,” Bethesda, MD
March 26, 2014: Invited Speaker, White House OMB Roundtable
on Exploring the the Use of Low-Cost Randomized Experiments to
42. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 42
Advance Evidence-Based Government, “Rediscovering Low-Cost
Randomized Trials in an Era of Big Data and Small Budgets,”
Washington, DC
March 31, 2014: Invited Speaker, American College of Cardiology
session on the Impact of the Evolving Health Landscape on the
Academic Mission, “Perspective of the NHLBI,” Washington, DC
April 2, 2014: Invited Speaker, Workshop on Innovative Study
Designs and Methods for Developing, Testing, and Implementing
Behavioral Interventions to Improve Health, “The Need for
Creative New Methods in Clinical Research,” Washington, DC
April 9, 2014: Invited Speaker, American Society of Hematology
Government Affairs Committee, “Supporting Biomedical Research
in Tough Fiscal Times – Thoughts from the NHLBI,” Washington,
DC
April 29, 2014: Invited Speaker, Workshop on Pathways to
Improved Risk Stratification, “Supporting Biomedical Research in
Tough Fiscal Times – Throughts from the NHLBI,” Crystal City,
VA
May 16, 2014: Invited Speaker for the 4th
Shiu Kwong Ho
Memorial Lecture at the Beth Israel Deaconess Hospital,
“Supporting Biomedical Research in Tough Fiscal Times …
Thoughts from the NHLBI,” Boston, MA
May 29, 2014: Invited Speaker, NHLBI Workshop on Salt in
Human Health and Sickness, “Perspectives from the NHLBI on
Portfolio Prediction and Performance,” Bethesda, MD
June 20, 2014: Invited Speaker, NIH Scientific Program and
Review Interest Group (SPRIG), “Perspectives from the NHLBI
on Portfolio Prediction and Performance,” Bethesda, MD
June 22, 2014: Invited Plenary Speaker, American Society of
Echocardiography, “The Cost of Innovation: NHLBI
Perspectives,” Portland, OR
43. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 43
July 11, 2014: Invited Grand Rounds Speaker, NIH Common Fund
HCS Collaboratory, “Portfolio Evaluation from the Field –
Perspective of the NHLBI,” Bethesda, MD
July 28, 2014: Invited presentation at the White House, White
House Office of Science and Technology Policy (OSTP)
Conference on Low-Cost Randomized Controlled Trials,
“Rediscovering Low-Cost Randomized Trials in an Era of Big
Data and Small Budgets,” Washington, DC
July 29, 2014: Invited Speaker, MCRN Scientific Lead and
Investigator Retreat, “Barriers of Clinical Trials in the US to Meet
Public Health Needs,” Washington, DC
August 19, 2014: Invited Speaker, NIH Common Fund HCS
Collaboratory Steering Committee, “The Collaboratory at Age 2:
Back to the Future,” Bethesda, MD
September 15, 2014: Invited Speaker, American College of
Cardiology Legislative Conference, “Supporting Biomedical
Research in Tough Fiscal Times – Thoughts from the NHLBI,”
Washington, DC
September 19, 2014: Invited Speaker, Building Industry
Government Academic Partnerships Workshop, National Academy
of Sciences, “Welcome and Thoughts from the NHLBI,”
Washington, DC
September 22, 2014: Invited Keynote Address, Southeastern
Conference Symposium on Prevention of Obesity, Overcoming a
21st
Century Public Health Challenge, “Setting an Agenda for
Obesity Prevention – Asking the Right Questions,” Atlanta, GA
September 29, 2014: Invited Speaker, NHLBI K Award
Investigators’ Meeting, “Supporting Biomedical Research in
Tough Fiscal Times – Thoughts from the NHLBI,” Bethesda, MD
44. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 44
September 30, 2014: Invited Speaker, NHLBI Arterial Stiffness
Grantees Meeting, “Supporting Biomedical Research in Tough
Fiscal Times – Thoughts from the NHLBI,” Bethesda, MD
October 1, 2014: Invited Speaker and Visting Professor, University
of Maryland School of Medicine, Medical Grand Rounds,
“Supporting Biomedical Research in Tough Fiscal Times –
Thoughts from the NHLBI,” Baltimore, MD
October 7, 2014: Invited Speaker, National Cancer Institute (NCI)
Community Oncology Research Program, “Practical Trials in
Outcomes Science – Thoughts from the NHLBI,” Rockville, MD
October 9, 2014: Invited Speaker, NIH National Children’s Study
Review Committee, “Preliminary Test Analyses of Birth Weight in
the National Children’s Vanguard Study,” Bethesda, MD
October 15, 2014: Invited Speaker, NHLBI Office of Biostatistics
Research Seminar, “Perspectives on Portfolio Prediction and
Performance,” Bethesda, MD
October 20, 2014: Invited Speaker, CSR Advisory Council
Meeting, “Perspectives from the NHLBI on Portfolio Prediction
and Performance,” Bethesda, MD
October 28, 2014: Invited Speaker, NIGMS Seminar, “Portfolio
Productivity, Field Stories from NHLBI,” Bethesda, MD
October 28, 2014: Invited (Remote) Speaker, Framingham Heart
Study Research Conference, “Funding Epidemiology and
Population Science in Times of Bigger Data and Smaller Budgets,”
Framingham, MA
November 4, 2014: Invited Seminar Speaker, NIH FAES Graduate
School of Public Health, “The Case for Comparative Effectiveness
Research,” Bethesda, MD
45. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 45
November 17, 2014: Invited Plenary Speaker, American Heart
Association, “Risk Assessment in Primary Prevention – Future
Directions,” Chicago, IL
November 17, 2014: Invited Cardiovascular Symposium Speaker,
American Heart Association, “NHLBI and Its Role [in the AHA
CV GPS Project],” Chicago, IL
2015 (Selected):
January 23, 2015: Invited Speaker, NIBIB Advisory Council
Meeting, “Perspectives from the NHLBI on Portfolio Prediction
and Performance,” Bethesda, MD
February 3, 2015: Invited Speaker, NHLBI Pragmatic Trials
Grantee Meeting, “A Tale of Two Books (and Some Journal
Articles, and a Poem),” Rockville, MD
February 11, 2015: Invited Speaker, NIH Workshop on Precision
Medicine, “Building a Large US Cohort,” Bethesda, MD
March 2, 2015: Keynote Speaker, 25th
Anniversay Celebration of
the Welch Center, Johns Hopkins University Bloomberg School of
Public Health, “The Future of Observational Studies and Clinical
Trials,” Baltimore, MD
March 4, 2015: Invited Plenary Speaker, American Heart
Assocation Epi/Lifestyle Meeting, “eData Sciences and
Epidemiology,” Baltimore, MD
March 10, 2015: Invited Speaker, Institute of Medicine Roundtable
on Translating Genomic-Based Research for Health, “Precision
Medicine: NIH Perspectives,” Washington, DC
March 19, 2015: Invited Speaker, NHLBI Office of Management
Senior Leadership Team, “Developing an Evidence-Based, Data-
Driven Culture – Field Stories from DCVS,” Bethesda, MD
46. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 46
March 30, 2015: Invited Speaker, MRCT Conference on
Promoting Clinical Trial Data Transparency at the Harvard Faculty
Club, “NHLBI Data Repository (BioLINCC),” Cambridge, MA
April 1, 2015: Invited Speaker, NIDDK Meeting on Urinary Stone
Disease, “Pragmatic Clinical Trials: Databases, Registries, and
Electronic Health Records,” Bethesda, MD
April 16, 2015: Invited Grand Rounds Speaker, Johns Hopkins
University Department of Anesthesiology and Critical Care
Medicine, “Supporting Biomedical Research in Tough Fiscal
Times – Thoughts from NHLBI,” Baltimore, MD
April 27, 2015: Invited Speaker, American Heart Association Data
Summit, “NHLBI and NIH Data Repositories – BioLINCC and
dbGaP,” Baltimore, MD
May 7, 2015: Invited Speaker, Women’s Health Initiative Annual
Meeting, “Supporting Clinical Research in Tough Fiscal Times,”
Bethesda, MD
May 13, 2015: Invited Speaker, NIH Committee on Efficient and
Sustainable Funding Policies, “Developing Efficient and
Sustainable Funding Policies: An Analysis of the Productivity of
NHLBI Cardiovascular Scientists,” Bethesda, MD
May 14, 2015: Invited Speaker, NIA Extramural Seminar,
“Efficient and Sustainable Funding – Analyses of the Productivity
of NHLBI Cardiovascular Scientists,” Bethesda, MD
May 20,2015: Invited Keynote Speaker (Founders Lecture),
Society for Clinical Trials, “Is There a Future for Clinical Trials?,”
Arlington, VA
47. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 47
EDITORIAL WORK:
1994-2000 Associate Editor, Journal Watch in Cardiology, Massachusetts
Medical Society
1994- Abstract Grader, American College of Cardiology
1995- Peer Review: New England Journal of Medicine (NEJM), Journal
of the American Medical Association (JAMA), Lancet, Annals of
Internal Medicine, Preventive Medicine, Hypertension, American
Journal of Physiology, Journal of General Internal Medicine,
Circulation, American Journal of Cardiology, American Heart
Journal, American Journal of Medicine, Journal of the American
College of Cardiology, Journal of Thoracic and Cardiovascular
Surgery, Coronary Artery Disease, American Journal of
Gastroenterology, Kidney International
1998 Reviewer for American Medical Informatics Society Annual
Symposium
2000- Abstract Grader, American Heart Association
2000-2007 Contributing Editor, Journal of the American Medical Association
(JAMA)
2003-2007 Clinical Reviews Editor, Journal of the American Medical
Association (JAMA)
2009- Editorial Board, Annals of Internal Medicine
2012- Consulting Editor, Journal of the American College of Cardiology
2013- Consulting Editor, Circulation Research
2015- Consulting Editor, Scientific Data (Nature Publishing Group)
ACADEMIC APPOINTMENTS:
1992-1993 Clinical Instructor in Medicine, Harvard Medical School
1995-1998 Clinical Assistant Professor of Medicine in the College of
Medicine, Pennsylvania State University
1998-2007 Clinical Associate Professor Medicine in the College of Medicine,
48. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 48
Pennsylvania State University
2000-2007 Director of Clinical Research, Department of Cardiology,
Cleveland Clinic Foundation
2003-2007 Professor of Medicine, Cleveland Clinic Lerner College of
Medicine of Case Western Reserve University
2005-2007 Professor of Epidemiology and Biostatistics in the School of
Medicine of Case Western Reserve University
CLINICAL TRIALS:
1996 Clinical Events and ECG Committee, EPILOG Trial
1996-1999 Clinical Endpoints Committee, ACUTE Trial
1997-1999 Cleveland Clinic Foundation PI, ASSENT II Trial
National Steering Committee, GUSTO IV Trial
1997-2002 Associate Chairman, Cleveland Clinic Cardiovascular
Coordinating, Center, Electrocardiogram Core Laboratory
2003-2005 Member, DSMB of TAXUS V and TAXUS V ISR Trials
GRANT SUPPORT:
1998-2001 Screening for left ventricular dysfunction in asymptomatic, high
risk subjects with abbreviated echocardiography: American Heart
Association National Grant, David Baker, MD, Principal
Investigator, Michael S. Lauer, MD, Consultant. Cleveland Clinic
Foundation is receiving $25,000 for core laboratory
echocardiography interpretation.
1999-2002 Association of myocardial ischemia as assessed by dobutamine
echocardiography with plasma ANP and BNP levels obtained
before and after stress: grant from Promotion and Mutual Aid
Corporation for Private Schools of Japan and the Kansai Medical
University, 2nd
Department of Internal Medicine, Osaka, Japan,
Hisako Tsuji, MD, and Michael S. Lauer, MD, Principal
Investigators. Cleveland Clinic Foundation is receiving $23,000
for recruiting patients and coordinating the project.
49. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 49
2000-2002 Computerized, heart rate adjusted exercise ST-segment analyses
and prediction of all-cause mortality. Established Investigator
Grant, American Heart Association, Michael S. Lauer, MD,
Principal Investigator, approximately $140,000 over three years.
2001-2004 Heart rate recovery and mortality. National Institutes of Health
R01HL66004-01, initiating March 1, 2001, $660,000 over three
years.
2003-2004 The Association of the Mediwave Ischemic Index with Myocardial
Perfusion Abnormalities: A Prospective Pilot Study. $35,000 over
one year.
2004-2008 Logical Analysis of Data and Cardiac Surgical Risk. National
Institutes of Health R01HL-072771, $1,032,000 over 3-4 years.
2005-2010 PI of Core E (Clinical Research Skills and Development Core) of
National Institutes of Health SCCOR grant P50 HL77107 (Eric J.
Topol, MD, PI), $500,000 over 5 years for this Core.
2005-2007 American Arthritis Foundation Grant, “Mortality Outcomes in
Pediatric Rheumatology” – PI – Philip Hashkes, Consultant.
OUTSIDE/COMMUNITY ACTIVITIES:
I am actively involved in the Kemp Mill Synagogue, a Modern Orthodox Jewish
congregation attending daily minyanim, leading services, and on an occasional basis
reading Torah (“leining”) and giving Torah-oriented talks. I completed a 4-year term as a
Member of the Beachwood Kehilla Board of Trustees, serving as Recording Secretary. I
regularly participate in Torah study, including the daily Daf Yomi program. I enjoy
reading books about economics, history, science, and cognitive/organizational
psychology.
50. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 50
Bibliography1–305
1. Danthi NS, Wu CO, DiMichele DM, Hoots WK, Lauer MS. Citation Impact of NHLBI
R01 Grants Funded Through the American Recovery and Reinvestment Act as Compared
to R01 Grants Funded Through a Standard Payline. Circ Res. 2015;116:784–8.
2. Harrington RA, Barac A, Brush JE, Hill JA, Krumholz HM, Lauer MS, Sivaram CA,
Taubman MB, Williams JL. COCATS 4 Task Force 15: Training in Cardiovascular
Research and Scholarly Activity. J Am Coll Cardiol. 2015;65:1899–906.
3. Lauer MS, Gordon D, Olive M. Matching Taxpayer Funding to Population Health Needs:
Not so Simple. Circ Res. 2015;116:1301–3.
4. Lauer MS, Kiley JP, Mockrin SC, Mensah GA, Hoots WK, Patel Y, Cook NL, Patterson
AP, Gibbons GH. National Heart, Lung, and Blood Institute (NHLBI) Strategic Visioning:
Setting an Agenda Together for the NHLBI of 2025. Circulation. 2015;131:1106–9.
5. Sorlie PD, Sholinsky P, Lauer MS. Reinvestment in Government-Funded Research: A
Great Way to Share. Circulation. 2015;131:17–8.
6. Collins FS, Hudson KL, Briggs JP, Lauer MS. PCORnet: turning a dream into reality. J
Am Med Inf Assoc. 2014;21:576–577.
7. Danthi N, Wu CO, Shi P, Lauer M. Percentile ranking and citation impact of a large
cohort of national heart, lung, and blood institute-funded cardiovascular R01 grants. Circ
Res. 2014;114:600–606.
8. Eapen ZJ, Lauer MS, Temple RJ. The imperative of overcoming barriers to the conduct of
large, simple trials. JAMA. 2014;311:1397–1398.
9. Kaltman JR, Evans FJ, Danthi NS, Wu CO, DiMichele DM, Lauer MS. Prior publication
productivity, grant percentile ranking, and topic-normalized citation impact of NHLBI
cardiovascular R01 grants. Circ Res. 2014;115:617–24.
10. Lauer MS. Personal reflections on big science, small science, or the right mix. Circ Res.
2014;114:1080–1082.
11. Lauer MS. Investing in clinical science: make way for (not-so-uncommon) outliers. Ann
Intern Med. 2014;160:651–652.
12. Lauer MS, Bonds D. Eliminating the “expensive” adjective for clinical trials. Am Hear J.
2014;167:419–420.
13. Lauer MS. Commentary on Vickers. Clin Trials. 2014;11:622–623.
51. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 51
14. Lauer MS. Time to bring the “electrocardio-ome” into modern cardiovascular
epidemiology? J Am Coll Cardiol. 2014;64:907–909.
15. Gordon DJ, Lauer MS. Publication of trials funded by the National Heart, Lung, and
Blood Institute. N Engl J Med. 2014;370:782.
16. Lauer MS. The basic science that is epidemiology. JACC Cardiovasc Imaging.
2014;7:879–881.
17. Witt CM, Rafferty Withers S, Grant S, Lauer MS, Tunis S, Berman BM. What can
comparative effectiveness research contribute to integrative health in international
perspective? J Altern Complement Med. 2014;20:874–880.
18. Dubois RW, Lauer M, Perfetto E. When is evidence sufficient for decision-making? A
framework for understanding the pace of evidence adoption. J Compar Eff Res.
2013;2:383–391.
19. Gibbons GH, Shurin SB, Mensah GA, Lauer MS. Refocusing the agenda on
cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood
Institute. J Am Coll Cardiol. 2013;62:1396–8.
20. Gordon D, Taddei-Peters W, Mascette A, Antman M, Kaufmann PG, Lauer MS.
Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J
Med. 2013;369:1926–1934.
21. Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle
RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS,
Lauer MS, Meyerhardt JA, Olopade OI, Palmer JR, Sellers TA, Seminara D, Ransohoff
DF, Rebbeck TR, Tourassi G, Winn DM, Zauber A, Schully SD. Transforming
epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers
Prev. 2013;22:508–516.
22. Lauer MS. Rigorous science as the road to better public health. Popul Heal Metr.
2013;11:10.
23. Lauer MS, D’Agostino Sr. RB. The randomized registry trial--the next disruptive
technology in clinical research? N Engl J Med. 2013;369:1579–1581.
24. Pearson GD, Kaltman JR, Lauer MS. Evidence-based medicine comes of age in pediatric
cardiology. J Am Coll Cardiol. 2013;61:2565–7.
25. Sorlie PD, Bild DE, Lauer MS. Cardiovascular Epidemiology in a Changing World-
Challenges to Investigators and the National Heart, Lung, and Blood Institute. Am J
Epidemiol. 2012;175:597–601.
52. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 52
26. Blajchman MA, Carson JL, Eikelboom JW, Heddle NM, Lacroix J, Lauer MS, Platt R,
Tilley B, Triulzi D, Vickers AJ, Yusuf S, Glynn S, Mondoro TH, Wagner E. The role of
comparative effectiveness research in transfusion medicine clinical trials: proceedings of a
National Heart, Lung, and Blood Institute workshop. Transfusion. 2012;52:1363–1378.
27. Galis ZS, Hoots WK, Kiley JP, Lauer MS. On the value of portfolio diversity in heart,
lung, and blood research. Am J Respir Crit Care Med. 2012;186:575–578.
28. Hlatky MA, Douglas PS, Cook NL, Wells B, Benjamin EJ, Dickersin K, Goff DC, Hirsch
AT, Hylek EM, Peterson ED, Roger VL, Selby J V, Udelson JE, Lauer MS. Future
directions for cardiovascular disease comparative effectiveness research: report of a
workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol.
2012;60:569–580.
29. Lauer MS. Lemons for Obesity. Ann Intern Med. 2012;
30. Lauer MS. Responses to commentaries. Stat Med. 2012;
31. Lauer MS. A policy for science. J Am Coll Cardiol. 2012;59:2154–2156.
32. Lauer MS. Advancing Cardiovascular Research. Chest. 2012;141:500–505.
33. Lauer MS. From hot hands to declining effects: the risks of small numbers. J Am Coll
Cardiol. 2012;60:72–74.
34. Lauer MS. And what about exercise? Fitness and risk of death in “low-risk” adults. J Am
Hear Assoc. 2012;1:e003228.
35. Lauer MS. Time for a creative transformation of epidemiology in the United States.
JAMA. 2012;308:1804–1805.
36. Lauer MS. Commentary: How the debate about comparative effectiveness research should
impact the future of clinical trials. Stat Med. 2012;31:3051–3053.
37. Pattakos G, Koch CG, Brizzio ME, Batizy LH, Sabik JF, Blackstone EH, Lauer MS.
Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment
with severe blood conservation. Arch Intern Med. 2012;172:1154–1160.
38. Schwartz S, Lauer M, McNeil B, Tunis S, Diamond G, Silber J, Herzig A, Temple B, Lee
J, Rhodes K, Morton S, Rotelli M. Panel discussion 1. Clin Trials. 2012;9:13–21.
39. Lauer MS. Advancing the paradigm for cardiovascular imaging research. J Nucl Cardiol.
2012;19:5–8.
53. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 53
40. Cook NL, Lauer MS. The socio-geography of heart failure: why it matters. Circ Hear
Fail. 2011;4:244–245.
41. Gorodeski EZ, Ishwaran H, Kogalur UB, Blackstone EH, Hsich E, Zhang ZM, Vitolins
MZ, Manson JE, Curb JD, Martin LW, Prineas RJ, Lauer MS. Use of Hundreds of
Electrocardiographic Biomarkers for Prediction of Mortality in Postmenopausal Women
The Women’s Health Initiative. Circ Qual Outcomes. 2011;4:521–532.
42. Hattori N, Carrino DA, Lauer ME, Vasanji A, Wylie JD, Nelson CM, Apte SS.
Pericellular versican regulates the fibroblast-myofibroblast transition: a role for
ADAMTS5 protease-mediated proteolysis. J Biol Chem. 2011;286:34298–34310.
43. Hsich E, Gorodeski EZ, Blackstone EH, Ishwaran H, Lauer MS. Identifying important
risk factors for survival in patient with systolic heart failure using random survival forests.
Circ Cardiovasc Qual Outcomes. 2011;4:39–45.
44. Lauer MS. Cardiovascular Science in the Service of National Strength. Jama-Journal Am
Med Assoc. 2011;306:2145–2146.
45. Lauer MS. Advancing the paradigm for cardiovascular imaging research. J Nucl Cardiol.
2011;
46. Lauer MS. What Now With Screening Electrocardiography? Ann Intern Med.
2011;155:395–397.
47. Lauer MS. How will exercise capacity gain enough respect? Circulation. 2011;123:1364–
1366.
48. Lauer MS. Thought exercises on accountability and performance measures at the National
Heart, Lung, and Blood Institute (NHLBI): an invited commentary for circulation
research. Circ Res. 2011;108:405–409.
49. Lauer MS. Commentary: Will academia embrace comparative effectiveness research?
Acad Med. 2011;86:671–673.
50. Lauer MS. Heart rate recovery: what now? J Intern Med. 2011;270:597–599.
51. Lauer MS. Pseudodisease, the Next Great Epidemic in Coronary Atherosclerosis? Arch
Intern Med. 2011;171:1268–1269.
52. Lauer MS. Pseudodisease, the next great epidemic in coronary atherosclerosis?: comment
on “Impact of coronary computed tomographic angiography results on patient and
physician behavior in a low-risk population.” Arch Intern Med. 2011;171:1268–1269.
54. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 54
53. Lauer MS, Hodes R. Epidemiology, Comparative Effectiveness Research, and the
National Institutes of Health Forces for Health. Epidemiology. 2011;22:625–628.
54. Rader F, Costantini O, Jarrett C, Gorodeski EZ, Lauer MS, Blackstone EH. Quantitative
electrocardiography for predicting postoperative atrial fibrillation after cardiac surgery. J
Electrocardiol. 2011;44:761–767.
55. Hashkes PJ, Wright BM, Lauer MS, Worley SE, Tang AS, Roettcher PA, Bowyer SL.
Survival Rates of Children With Acute Lymphoblastic Leukemia Presenting to a Pediatric
Rheumatologist in the United States. J Pediatr Hematol Oncol. 2011;33:424–428.
56. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky
MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith Jr. SC, Taylor AJ, Weintraub
WS, Wenger NK, Jacobs AK. 2010 ACCF/AHA guideline for assessment of
cardiovascular risk in asymptomatic adults: executive summary: a report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice
Guidelines. Circulation. 2010;122:2748–2764.
57. Ishwaran H, Kogalur UB, Gorodeski EZ, Minn AJ, Lauer MS. High-dimensional variable
selection for survival data. J Am Stat Assoc. 2010;105:205–217.
58. Lauer MS. The historical and moral imperatives of comparative effectiveness research.
Stat Med. 2010;29:1982–1987.
59. Lauer MS. National Heart, Lung, and Blood Institute and the American Recovery and
Reinvestment Act of 2009: 1 year later. J Am Coll Cardiol. 2010;56:234–236.
60. Lauer MS. Screening asymptomatic subjects for subclinical atherosclerosis: not so
obvious. J Am Coll Cardiol. 2010;56:106–108.
61. Lauer MS, Collins FS. Using science to improve the nation’s health system: NIH's
commitment to comparative effectiveness research. JAMA. 2010;303:2182–2183.
62. Lauer MS, Skarlatos S. Translational research for cardiovascular diseases at the National
Heart, Lung, and Blood Institute: moving from bench to bedside and from bedside to
community. Circulation. 2010;121:929–933.
63. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund
K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS,
Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond
WD. Defining and Setting National Goals for Cardiovascular Health Promotion and
Disease Reduction. The American Heart Association’s Strategic Impact Goal Through
2020 and Beyond. Circulation. 2010;
55. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 55
64. Mark DB, Berman DS, Budoff MJ, Carr JJ, Gerber TC, Hecht HS, Hlatky MA, Hodgson
JM, Lauer MS, Miller JM, Morin RL, Mukherjee D, Poon M, Rubin GD, Schwartz RS,
Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Jacobs AK, Kaul S,
Moliterno DJ, Rosenson RS, Stein JH, Weitz HH, Wesley DJ.
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 Expert Consensus Document on
Coronary Computed Tomographic Angiography: a report of the American College of
Cardiology Foundation Task Force on Expert Consensus Documents. Circulation.
2010;121:2509–2543.
65. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky
MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith Jr. SC, Taylor AJ, Weintraub
WS, Wenger NK, Jacobs AK. 2010 ACCF/AHA guideline for assessment of
cardiovascular risk in asymptomatic adults: a report of the American College of
Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation. 2010;122:e584–636.
66. Hashkes PJ, Wright BM, Lauer MS, Worley SE, Tang AS, Roettcher PA, Bowyer SL.
Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum. 2010;62:599–
608.
67. Lauer MS. Risk stratification for sudden cardiac death: a puzzle beyond p values. J Am
Coll Cardiol. 2010;56:1484–1485.
68. Bild DE, Lauer MS. How one program at the National Heart, Lung, and Blood Institute
establishes its scientific priorities. J Am Coll Cardiol. 2009;53:2259–2261.
69. Douglas PS, Taylor A, Bild D, Bonow R, Greenland P, Lauer M, Peacock F, Udelson J.
Outcomes research in cardiovascular imaging: report of a workshop sponsored by the
National Heart, Lung, and Blood Institute. Circ Cardiovasc Imaging. 2009;2:339–348.
70. Gorodeski EZ, Cantillon DJ, Goel SS, Kaufman ES, Martin DO, Hsich EM, Blackstone
EH, Lauer MS. Microvolt T-wave alternans, peak oxygen consumption, and outcome in
patients with severely impaired left ventricular systolic function. J Hear Lung Transpl.
2009;28:689–696.
71. Gorodeski EZ, Ishwaran H, Blackstone EH, Lauer MS. Quantitative electrocardiographic
measures and long-term mortality in exercise test patients with clinically normal resting
electrocardiograms. Am Hear J. 2009;158:61–70 e1.
72. Hsich E, Gorodeski EZ, Starling RC, Blackstone EH, Ishwaran H, Lauer MS. Importance
of treadmill exercise time as an initial prognostic screening tool in patients with systolic
left ventricular dysfunction. Circulation. 2009;119:3189–3197.
73. Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, Gwinn M,
Simons-Morton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ,
56. Michael S. Lauer, MD, FACC, FAHA
Curriculum Vitae
Page 56
Collins FS, Croyle RT, Davis BR, Downing GJ, Duross A, Friedman S, Gail MH,
Ginsburg GS, Green RC, Greene MH, Greenland P, Gulcher JR, Hsu A, Hudson KL,
Kardia SL, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF, Roberts JS,
Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke KL, Witte JS, Xu
J. The Scientific Foundation for personal genomics: recommendations from a National
Institutes of Health-Centers for Disease Control and Prevention multidisciplinary
workshop. Genet Med. 2009;11:559–567.
74. Lauer MS. CT angiography: first things first. Circ Cardiovasc Imaging. 2009;2:1–3.
75. Lauer MS. Elements of danger--the case of medical imaging. N Engl J Med.
2009;361:841–843.
76. Lauer MS. Discarding logic: 2008 Ancel Keys Memorial Lecture. Circulation.
2009;119:1533–1537.
77. Lauer MS. Autonomic function and prognosis. Cleve Clin J Med. 2009;76 Suppl 2:S18–
22.
78. Lauer MS. Comparative effectiveness research: the view from the NHLBI. J Am Coll
Cardiol. 2009;53:1084–1086.
79. Lauer MS, Skarlatos SI, Bild DE. The Extramural Division of Cardiovascular Sciences of
the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2009;54:265–268.
80. Lauer MS, Sorlie P. Alcohol, cardiovascular disease, and cancer: treat with caution. J Natl
Cancer Inst. 2009;101:282–283.
81. Nabel EG, Lauer MS. The cardiovascular programs of the National Heart, Lung, and
Blood Institute: from vision to action to impact. J Am Coll Cardiol. 2009;53:1082–1083.
82. Shishehbor MH, Madhwal S, Rajagopal V, Hsu A, Kelly P, Gurm HS, Kapadia SR, Lauer
MS, Topol EJ. Impact of blood transfusion on short- and long-term mortality in patients
with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2009;2:46–
53.
83. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ,
Page RL, Passman RS, Siscovick D, Stevenson WG, Zipes DP. American Heart
Association/american College of Cardiology Foundation/heart Rhythm Society scientific
statement on noninvasive risk stratification techniques for identifying patients at risk for
sudden cardiac death: a scientific statement from the America. Hear Rhythm. 2008;5:e1–
21.